The effects of nanopattern surface technology and targeted metabolic therapies on orthopaedic implant related infections by Hansom, Donald
  
 
 
 
 
 
 
 
 
Hansom, Donald (2017) The effects of nanopattern surface technology and 
targeted metabolic therapies on orthopaedic implant related infections. 
MD thesis. 
 
 
 
http://theses.gla.ac.uk/7917/  
 
 
 
 
Copyright and moral rights for this work are retained by the author 
A copy can be downloaded for personal non-commercial research or study, without prior 
permission or charge 
This work cannot be reproduced or quoted extensively from without first obtaining 
permission in writing from the author 
The content must not be changed in any way or sold commercially in any format or 
medium without the formal permission of the author 
When referring to this work, full bibliographic details including the author, title, 
awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
Glasgow Theses Service 
http://theses.gla.ac.uk/ 
theses@gla.ac.uk 
  
 The Effects of Nanopattern 
Surface Technology and Targeted 
Metabolic Therapies on 
Orthopaedic Implant Related 
Infections 
 
 
Donald Hansom  
MRCS, MBChB, BSc (Hons) 
 
Submitted in fulfilment of the requirements for 
the Doctor of Medicine 
 
School of Medicine College of Medical, Veterinary 
and Life Sciences  
 
University of Glasgow 
 
August 2016
  i 
Abstract 
Bacterial biofilm infections cause significant morbidity in orthopaedic joint 
replacement. One of the most common bacteria in orthopaedic prosthetic 
infections is Staphylococcus aureus. Infection causes implant failure due to 
bacterial adherence and subsequent biofilm production. Nanotopography refers 
to the topography of a surface at the nanometre level and has major effects on 
cell behaviour. Studies suggest that surface nanotopography impacts the 
differential ability of staphylococci species to adhere, and may reduce 
orthopaedic implant infection rate. This research thesis focuses on bacterial 
adhesion on nanofabricated materials, and investigates the related metabolic 
changes and possible interventions.  
 
Staphylococcus aureus growth and quantification methods were optimised, with 
regard to growth media, incubation time and lysozyme incubation time. Both 
polystyrene and titanium (Ti) nanosurfaces were studied. Adhesion analysis was 
performed using fluorescence imaging, quantitative PCR, and bacterial 
percentage coverage. Metabolomic analysis was conducted by substitution with 
‘heavy’ labelled glucose into growth medium, thus allowing for bacterial 
metabolomic analysis and identification of up-regulated, labelled metabolites 
and pathways. 
 
Bacterial growth was optimal using DMEM + supplement media, with adhesion 
occurring after 1hr bacterial incubation. Optimal lysozyme incubation for 
bacterial quantification using qPCR was 2hr. These parameters were used for all 
subsequent experimentation. Surface topography affects cell behaviour, 
bacterial adhesion and long term implant survival can be affected. This study 
found reduced bacterial adhesion on the SQ and HEX polystyrene patterns. While 
not found to be significant, this trend was supported by a lower average 
percentage bacterial coverage on both the SQ and HEX patterns (P=0.05 and 
P=0.01, respectively). It may be that the SQ and HEX nanopatterns are the 
optimal nanopit orientation required to prevent bacteria microcolony formation, 
keeping the bacteria in small, isolated clusters. In addition, this series of 
investigations showed an increase in bacterial concentrations on both the 2.5Hr 
(P<0.05) and 3Hr (P<0.01) treated Ti nanowire discs when compared to the 
  ii 
polished Ti control disc, suggesting nanoroughness increases are associated with 
elevated bacterial adhesion. This theory was further supported by average 
percentage coverage, being significantly higher on the 2.5Hr and 3Hr treated 
discs (P<0.001). If, however, a disordered NC Ti nanopattern, hexagonal in 
nature, is used bacterial adhesion is significantly reduced when compared to a 
polished, control surface (P<0.05). The bacterial percentage coverage was also 
noted to be significantly lower on the NC surfaces, with over a 10-fold reduction 
when compared to the control surface. It is postulated that this reduction is 
through similar mechanisms to those described by Ivanova et al, and primarily 
related to altered surface interactions. Metabolomic analysis demonstrated 
increased intensity counts for key metabolites (pyruvate, aspartate, alanine and 
carbamoyl aspartate) involved in bacterial aggregation, proteoglycan and DNA 
synthesis. These pathways are also known to be important in bacterial biofilm 
production. Therapeutic targeting of these pathways (CA and β-CLA) was found 
to result in significantly reduced bacterial adhesion. 
 
This study shows that by altering nanotopography bacterial adhesion, and 
therefore, biofilm formation can be affected. Specific nanopatterned surfaces 
may reduce implant infection associated morbidity and mortality. The 
identification of metabolic pathways involved in adhesion allows for a targeted 
approach to biofilm eradication in S. aureus. This is of significant benefit to the 
patient, the surgeon and the NHS, and may well extend far beyond the realms of 
orthopaedics. 
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1.1 Implantable medical devices 
The history, development and current usage of medical implants will now be 
discussed, with emphasis on orthopaedic joint replacement surgery and the 
materials used therein. 
1.1.1 Medical implants 
Implantable medical devices or biomaterials are used extensively in modern 
medicine. They are defined as substances other than food or drugs that are 
contained in therapeutic or diagnostic systems (Peppas and Langer 1994). They 
have been used throughout history, playing an important role in the treatment 
of disease and improvement of health care (Langer and Tirrell 2004). 
Historically, biomaterials such as gold were used in dentistry by the Romans, 
Chinese and Aztecs, and recorded history highlights the use of wooden teeth and 
glass eyes (Ratner 2004). Since the development of synthetic materials at the 
turn of the nineteenth century, biomaterials have become increasingly used in 
health care. Polymethylmathacrylate (PMMA) was found to evoke only a mild 
foreign body reaction, and was subsequently used in dentistry in the 1930s, and 
later by Sir John Charnley in the 1960s as the basis for the cement used in total 
hip joint replacements (THR) (Ratner 2004). He suggested that the bone cement 
was used as a ‘grout’ rather than an ‘adhesive’, and that fixation was achieved 
by interlocking. This allowed the body weight to be more evenly distributed and 
dispersed over a larger surface area, signalling a turning point in THR (Charnley 
1960). In addition to cement, Charnley also developed the use of 
polytetrafluoroethylene (PTFE) as a synthetic cartilage, designed to line the 
acetabulum of the pelvis. However, despite promising laboratory predictions 
PTFE showed significant wear within the first few years, resulting in high 
volumes of wear debris that elicited an intense foreign body reaction. Following 
this catastrophic failure, Charnley began to use Ultra High Molecular Weight 
Polyethylene (UHMWP), which at the time was used in the impact bearings of 
mechanical looms, and he found this biomaterial to have superior wear 
properties to that of PTFE (Gomez and Morcuende 2005). The qualities that 
made this particular biomaterial the ideal choice for THR were, excellent wear 
Ch. 1 Introduction 
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resistance, low friction and high impact strength, attributes that remain similar 
even today (Kurtz, Muratoglu et al. 1999). In addition to orthopaedics, 
biomaterials are used throughout the field of medicine. For instance 
cardiothoracic heart valve replacements can be fabricated from a variety of 
substances, such as carbons, metals, elastomers, fabrics and natural products 
(i.e. porcine). These can dramatically improve cardiac function following 
implantation leading to a rapid improvement in symptoms (Ratner 2004). Dental 
implants have been previously mentioned in relation to PMMA; however, the 
widespread use of titanium implants to form artificial roots for crown fixation 
has transformed implantology. Titanium has been found to provide a tight seal 
(via osseointegration) against bacterial invasion, and appears to form a tight 
apposition with the bone in the jaw improving implant longevity (Ratner 2004). 
Intraocular lenses made from PMMA or silicone are used to replace the natural 
lens of the eye when damaged or cataractous (Lloyd, Faragher et al. 2001). 
Good vision can be restored almost immediately and the success rate is reported 
at over 85% (Foster, Fong et al. 1989). 
It is clear from the above examples that biomaterial science is an ever 
expanding, important and useful area of development that has the ability to 
significantly improve patient morbidity and mortality. Simple interventions, such 
as intra-venous cannulas right through to complex orthopaedic prosthetic 
replacements, all have their foundations in biomaterial science. As previously 
mentioned, a wide variety of biomaterials have been used throughout history 
and in numerous medical sub-specialities. One of the largest demands on 
biomaterials today is from the orthopaedic community. 
 
1.1.2 Hip and knee joints 
1.1.2.1 The Hip joint 
The natural hip joint is a multi-axial ball and socket type synovial joint as shown 
in Figure 1-1. It consists of an articulation between the femoral head and the 
acetabulum of the pelvis, and with the addition of multiple ligaments, labral 
tissue and an articular capsule creates a highly mobile yet stable joint (Moore, 
Agur et al. 2002). 
Ch. 1 Introduction 
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Figure has been removed due to Copyright restrictions 
Figure 1-1 The native hip joint adapted from (System 2003) 
 
1.1.2.2 The Knee Joint 
In comparison, the knee joint is a hinge type synovial joint as shown in Figure 
1-2. It consists of 3 articulations, the lateral and medial articulations between 
the femoral and tibial condyles and the articulation between the patella and the 
femur anteriorly (Moore, Agur et al. 2002). In contrast to the hip joint, the bony 
geometry of the knee is inherently unstable and relies on a collection of strong 
ligaments for stability as well as a strong fibrous joint capsule.  
Figure has been removed due to Copyright restrictions 
 
Figure 1-2 The native knee joint. Adapted from (System 2003) 
 
Both joints, however, rely on intact articular cartilage for a smooth, pain free 
range of motion. Hyaline (meaning ‘glass-like’) cartilage covers articular 
surfaces of synovial joints and functions to distribute weight-bearing forces and 
reduce friction. It is entirely avascular, aneural and alymphatic and relies solely 
on diffusion from synovial fluid for nourishment (Ramachandran 2006). The 
primary constituent of cartilage is water (around 80% of total wet weight). The 
water is held in place by proteoglycans, which hold a negative charge and 
constitute 20% total wet weight. The water present in cartilage is primarily 
intermolecular and is able to move when a load or pressure is applied. This 
movement is however restricted by the frictional drag of macromolecules 
present within the cartilage. These decrease water flow and stiffen the 
cartilage, allowing greater resistance to higher loads. This allows the cartilage 
to ‘change’ its properties with load/compression and is known as a biphasic 
material that is visco-elastic (Ramachandran 2006). Additionally, cartilage is also 
anisotropic; having different mechanical properties depending on the direction it 
is loaded. This is due to the collagen fibres also present in cartilage (primarily 
type II collagen), which constitutes around 10-15% total wet weight. The 
collagen is arranged in a strong, mesh like arrangement due to multiple 
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crosslinks and collagen-proteoglycan interactions. When under tension, the 
structure of the articular cartilage, organisation of collagen fibres and cross-
links are altered. Cartilage is essentially pulled apart, allowing an influx of 
water and a decrease in compressive stiffness (Ramachandran 2006). 
Collectively, all of the above properties result in a material that is 
approximately ten times more effective as a shock absorber than bone and has 
an extremely low coefficient of friction (0.002). This is around 30 times 
smoother than most modern artificial joint replacements and represents a gold 
standard bearing (Ramachandran 2006). 
1.1.3 Prosthetic joint replacements 
Orthopaedic surgery plays a major role in the treatment of arthritis. Once 
medical management fails and symptoms are not controlled, joint replacement 
(arthroplasty) often provides the only treatment. Most total joint arthroplasty 
(TJA) involves the knee or the hip. In the United Kingdom in 2014 there were 
around 89,000 primary total hip replacement carried out and around 91,000 
total knee replacements, the majority of which were carried out for arthritic 
conditions (Scottish-Arthoplasty-Project 2014).  
Joint replacement refers to the artificial replacement of the natural joint. In 
general, joint replacements can either have both components cemented 
(cemented implant), neither component cemented (un-cemented implant) or 
have one component cemented and one un-cemented (femoral component 
cemented - hybrid implant, acetabular component cemented – reverse hybrid 
implant). The choice of implant is dependent on a variety of factors including 
surgeon preference, patient demographics and implant availability. Implant 
composition will be discussed in a later section. Figure 1-3 and Figure 1-4 
represent simplified diagrams of both a primary total knee replacement and 
primary total hip replacement respectively. 
 
Figure has been removed due to Copyright restrictions 
 
Figure 1-3 Primary THR, adapted from (Morphopaedics 2004). 
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Figure has been removed due to Copyright restrictions 
 
Figure 1-4 Primary TKR (Surgeon 2013). 
 
1.1.4 Orthopaedic biomaterials  
Many synthetic materials are utilised in TJA, and to be successful must fulfil 
certain primary criteria: 
• A high level of biocompatibility in order to avoid any inflammatory or 
toxic response beyond an acceptable tolerable level. 
• Appropriate mechanical properties, with a Young’s modulus of elasticity 
(a measurement of the stiffness of a material) similar to that of bone. 
• Economically viable manufacturing and processing methods. 
Implant selection is complex and depends on a variety of different parameters, 
such as patient age, reason for replacement and surgeon preference and will not 
be addressed in this project. A multitude of different materials are used in 
arthroplasty such as metals, ceramics, polymers and composites, which will now 
be briefly discussed.  
1.1.4.1 Metals 
Historically, metals have been used for centuries as a substitute for damaged 
human bones due to their superior mechanical properties, namely strength. 
Originally made from stainless steel, due to its ease of manufacture, corrosion 
resistance and increased strength, excessive loosening and increased friction 
were documented. This was likely due stainless steel’s high Young’s modulus of 
elasticity, causing increased stress shielding and ultimately implant failure 
(Learmonth, Young et al.), which forced a change to cobalt chrome. Whilst 
demonstrating improved corrosion resistance and biocompatibility, Young’s 
modulus of elasticity was also found to be significantly raised increasing overall 
strength (Ramachandran 2006). These femoral components of the THA are 
around 5-6 times stiffer than bone and therefore suffer from problems relating 
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to stress-shielding. The regenerative and remodelling processes in bone are 
directly triggered by loading, i.e. bone subjected to loading or stress 
regenerates and bone not subjected to loading results in atrophy (Wolff’s law 
(Ramachandran 2006)). Therefore, a much stiffer implant reduces the load on 
the bone and results in stress shielding (Katti 2004). This is a problem associated 
with Co-Cr and stainless steel, which are known to have a higher elastic modulus 
(230GPa and 190GPa respectively) than that of the most commonly used 
titanium alloys Ti-6A1-4V (110GPa) (Ramachandran 2006). Additionally, titanium 
alloys also show good wear characteristics, excellent biocompatibility and 
fatigue resistance, the downside being the relative expense (Learmonth, Young 
et al.), costing up to five times as much per kilogram than stainless steel. 
Titanium alloy implants are favourable materials for orthopaedic implants and 
are commonly used. They will therefore be the focus of this study. 
1.1.4.2 Acetabular components (UHMWP) 
The first acetabular components were also made from stainless steel, but 
suffered problems with fit in relation to articulating surfaces, high friction 
moments and excessive wear of the bearing surfaces (Chan, Bobyn et al. 1999). 
Charnley developed the use of PTFE and subsequently UHMWP as previously 
mentioned, which is still the most commonly used material for the acetabular 
component of THA today (Long and Rack 1998). UHMWP is however not without 
its risks and is known to wear with time when used in conjunction with a metal 
femoral head. This has led to the introduction of ceramics, both for the femoral 
and acetabular bearing surfaces. Current research is focusing mainly on different 
prosthetic combinations that will reduce contact stresses and therefore wear 
(Santavirta, Böhler et al. 2003, Katti 2004), however this relates to the joint 
surface only and not the bone-implant interface, and therefore will not be 
discussed in depth. 
1.1.4.3 Bone-implant interface 
When considering the bone-implant interface perhaps one of the most important 
advances was made in the 1960s, again by Charnley when he introduced PMMA as 
a bone cement (Ratner 2004). As previously mentioned Charnley suggested that 
bone cement should be used as a ‘grout’ rather than an ‘adhesive’, and that 
Ch. 1 Introduction 
 8 
fixation was achieved by interlocking (Charnley 1960). This allowed the body 
weight to be more evenly distributed and dispersed over a larger surface area, 
thus reducing stress shielding and improving implant survival. Whilst national 
joint registry results continue to show that cemented implants are being used 
(33% of all THR in 2012), un-cemented implants are increasing in usage (43% of 
all THR in 2012). It has been suggested this increase in usage is due to a superior 
outcome in younger patients (Eskelinen, Remes et al. 2006, Hooper, Rothwell et 
al. 2009) with improved osseointegration, specifically relating to the femoral 
component (Willert and Buchhorn 1998). The Swedish joint registry data suggests 
that un-cemented femoral components perform better than cemented stems, 
with the primary cause of un-cemented THR failure being due to loosening and 
wear-related problems of the acetabular component (Hailer, Garellick et al. 
2010). This would go some way to support the increase in reverse hybrid total 
hip replacements in the UK in the most recent national joint registry data (20% 
of all THR in 2012). In contrast, a recent meta-analysis suggested that cemented 
implants have a better short term clinical outcome than un-cemented devices, 
however overall implant survival rates are similar between prosthesis 
(Abdulkarim, Ellanti et al. 2013). Evidently the optimal method for fixation 
remains controversial, however it is recognised that if osseointegration can be 
achieved between implant and bone in un-cemented implants, then overall 
outcome improves as loosening is prevented. One approach to this is to coat 
implants with bioactive material (hydroxyapatite) that can promote 
osseointegration. Titanium lends itself well to such coating, resulting in 
significantly improved implant lifespans (Katti 2004). A comparison of current 
materials used in arthroplasty is shown in Table 1. 
Prosthesis Advantage Disadvantage 
Metal-on-polyethylene Predictable lifespan, cost 
effective 
Potential for high wear 
rate leading to aseptic 
loosening 
Ceramic-on-ceramic Low friction, low debris, 
inert. 
Expensive, can produce 
noise on movement 
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Metal-on-metal 
 
Reduced wear in 
comparison to metal-on-
polyethlene. Increased 
stability with large 
diameter heads. 
Metallosis due to metal 
ions, potential 
carcinogenic effect, 
aseptic lymphocyte 
dominated vasculitis-
associated lesions 
(ALVAL) 
Ceramic-on- 
polyethylene 
Lower wear rate than 
metal-on-poly 
Expensive 
Table 1 Comparison of materials used in arthroplasty, adapted from (Knight, 
Aujla et al. 2011, Cash and Khanduja 2014). 
 
1.2 Arthroplasty problems 
The various complications associated with arthroplasty with now be discussed, 
with focus on infection, current diagnostic methods and treatment strategies. 
1.2.1 Associated problems with Orthopaedic biomaterials 
Despite joint arthroplasty being one of the most successful and cost effective 
interventions in modern medicine, it is not without its complications. 
Improvements in surgical technique and implant design have contributed to a 
marked reduction in mortality after TJA (Parvizi, Holiday et al. 1999, Parvizi, 
Johnson et al. 2001). However, due to advances in preventative medicine, 
modern medical care and an aging population, overall patient survivorship is on 
the increase. This has resulted in arthroplasty being performed in older patients 
with significant comorbidities (Boettcher 1992, Pagnano, McLamb et al. 2003, 
Kreder, Berry et al. 2005). In addition, as osteoarthritis incidence increases with 
age, the overall number of arthroplasties being performed is also on the increase 
and current estimations suggest that by 2030, the demand for THR and TKR in 
the United States will increase by 174% and 673%, respectively (Kurtz, Ong et al. 
2007). It is therefore suggested that a higher overall number of complications 
associated with TJA will be observed in the future. 
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Complications associated with TJA can broadly be divided into systemic 
(medical) and local (orthopaedic).  
1.2.1.1 Systemic Complications 
Systemic complications can be further subdivided into either major or minor 
depending on their severity according to study by Parvizi et al, 2001, that 
prospectively analysed over 30,000 THA over a 28-year period (Parvizi, Johnson 
et al. 2001). Major complications constituted complex medical/surgical 
interventions, life threatening circumstances or a resultant functional 
impairment. Minor complications were defined as requiring a period of 
observation or medical treatment. They found the major systemic complication 
rate in TKA to be 4.9% and the minor rate to be 3.4%. Most life-threatening 
complications were cardiovascular in nature with the main constituent being 
that of pulmonary embolism (~1.8% overall incidence). The major complication 
rate in THA was 2%, with a minor rate of 3.1%. Again the most life-threatening 
complication was found to be pulmonary embolism with an overall incidence of 
1.5%. 
1.2.1.2 Local Complications 
These include infection, dislocation, peripheral nerve injury, periprosthetic 
fracture and vascular injury (Parvizi, Johnson et al. 2001). The most recent data 
taken from the Scottish arthroplasty report (Scottish-Arthoplasty-Project 2014) 
suggests that the most common complication is that of infection. Currently the 
risk of infection is around 1-1.5% at one year for large joint arthroplasty in the 
general population (Antti-Poika, Josefsson et al. 1990). The National Joint 
Registry data from the UK also supports the above documented risks, with 22% of 
TKR revisions and 12% of THR revisions being carried out because of infection in 
2012 (NJR 2013). Infection as a cause for revision was topped only by aseptic 
loosening (40% in THR and 32% in TKR) (NJR 2013). 
Infection of a prosthetic replacement is a serious postoperative complication, 
and continues to persist despite the use of prophylactic measures that include 
peri-operative systemic antibiotics, strict hygiene protocols and sterile laminar 
flow theatres (Belt, Neut et al. 2001). Even though infection appears to be 
implicated in a small percentage of operations, arthroplasty is so common (1 
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million/year worldwide (Neut, van Horn et al. 2003)) that a significant number 
of patients are affected. If infection is confirmed, the results can be devastating 
to both the patient and society. It can lead to severe consequences such as bone 
destruction, arthroplasty failure, amputation and even death due to general 
sepsis (Górecki and Babiak 2009). It is therefore associated with an increased 
morbidity, which significantly increases hospital length of stay and overall 
impact to the health care system, with the total cost estimated at around 
£450million worldwide annually (Sculco 1992).  
1.2.1.3 Diagnosing arthroplasty infection 
The aforementioned costs are based on confirmed bacterial infection by way of 
culture of intra-operative samples or joint aspiration. Unfortunately this may be 
misleading and the real extent of bacterial infection may be underestimated. 
Bacteria have been suggested to play a role in a proportion of the supposed 
aseptic loosening of prostheses. Josefsson et al (1990) noted that perioperative 
measures against infection not only lead to a decreased infection rate, but also 
the incidence of aseptic loosening (Josefsson, Gudmundsson et al. 1990). As 
methods of infection detection improve, the above theory is further supported 
(Neut, van Horn et al. 2003). At present the standard method for diagnosing 
bacterial infection is through isolation of responsible pathogens via culture of 
intra-operative or intra-articular samples. Problems with this method, such as 
diagnostic delay and sensitivity have been widely publicised (Hoeffel, Hinrichs et 
al. 1999). Whilst some cultures can be easily grown in a matter of days, some 
bacteria (especially anaerobes) often take considerably longer (Tunney, Patrick 
et al. 1999). In addition, small colonies of bacteria may not be isolated by the 
laboratory leading to false negative result. In addition concurrent antibiotic 
therapy in patients may also lead to false negative microbiological results (Neut, 
van Horn et al. 2003). It has therefore been suggested that standard culture 
techniques may not be identifying bacteria that are colonising orthopaedic 
implants (Dupont 1986). Indeed if diagnosis of infection was based on non-
culture techniques such as PCR or fluorescence scanning microscopy, then the 
reported incidence of infection has been shown to be higher when compared to 
the cultures alone (Lonner, Desai et al. 1996, Tunney, Patrick et al. 1999, 
Zimmerli, Trampuz et al. 2004). It is therefore concluded that, whilst current 
data suggests the infection rate in TJA is approximately 1-2%, in reality this 
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figure may be considerably higher and thus the importance of preventative 
measures in arthroplasty is clear. 
1.2.2 Orthopaedic implant infection 
Infection is able to reach prosthetic devices in two ways. Firstly from direct 
contamination intra-operatively (endogenous spread), usually from the patient 
or surgeons skin flora, from contaminated air in the operating room or 
contaminated instruments (Gristina, Hobgood et al. 1987). It is suggested that 
95% of arthroplasty infections occur within the 1st year following implantation 
(Lidwell, Lowbury et al. 1983) and that up to 63% of operations show 
contamination in the field of operation (primarily indirect surgical instruments 
such as sucker tips, light handles and gloves) (Davis, Curry et al. 1999). Further 
studies have cultured viable micro-organisms from instruments and tissue that 
have been in direct contact with the site of the prosthesis in 30% of all cases 
(Maathuis, Neut et al. 2005). 
The second way by which infection may reach prosthetic implants is via the 
bloodstream (Gristina, Hobgood et al. 1987). Haematogenous infection occurs 
after a pathogen is transported via the bloodstream or lymphatic system to the 
prosthesis. The original source is often distant to the prosthesis, such as a 
urinary tract infection, periodontal abscess or pneumonia. This haematogenous 
infective spread is thought to play a minor role in arthroplasty infection 
representing around 0.3-7% of all arthroplasty infections (Ainscow and Denham 
1984, Ahnfelt, Herberts et al. 1990). Bacteria isolated from orthopaedic 
infections are frequently the Staphylococcus species, namely coagulase-negative 
staphylococci (S. epidermidis) and S. aureus (Garvin, Hinrichs et al. 1999, 
Nickinson, Board et al. 2010). While some studies report that S. epidermidis and 
S. aureus are collectively responsible for 42-62% of all confirmed prosthetic joint 
infections (Trampuz and Widmer 2006), more recent epidemiological studies 
looking at almost 800 orthopaedic isolates from prosthetic infections, found  
that up to 79% of all infections were the result of Staphylococi, with two thirds 
(52%) being the result of either S. aureus or S. epidermidis, using culture 
techniques alone (Campoccia, Montanaro et al. 2006). Other bacterial species 
were found to represent around 22% of all prosthetic infections as summarised in 
Figure 1-5. These figures have further been supported by Ribeiro et al (2012), 
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whose review found that S. aureus and S. epidermidis collectively accounted for 
two thirds of all confirmed prosthetic joint infections in orthopaedics (Ribeiro, 
Monteiro et al. 2012). 
Figure has been removed due to Copyright restrictions 
 
Figure 1-5 Frequency of pathogenic species amongst orthopaedic clinical 
isolates of implant-associated infection (Campoccia, Montanaro et al. 2006). 
 
Infected prosthetic joints can be classified into three types. This was presented 
in 1975 by Coventry et al and is still relevant today (Coventry 1975): 
• Acute infection: - usually occurs within 3 weeks of the index procedure 
and represents a prosthesis that was infected from the outset, either with 
a wound did not heal or a haematoma. 
• Delayed infection: - Present after 3 weeks. Patient generally has a healed 
wound but continues to have problems, primarily pain, associated with 
the prosthesis. 
• Late haematogenous infection: - as mentioned previously, this is a 
secondary infection that arises from a remote site months to years after 
the index procedure. 
Most prosthetic joint infections are a result of delayed infection (Hernigou, 
Flouzat-Lachianette et al. 2010) and therefore this will be the focus of this 
study. Once confirmed, prosthetic infections can be treated in various ways. 
Current practice in most countries, in the case of early infection, is surgical 
debridement with the exchange of mobile components of the prosthesis and 
application of antibiotics (local +/- systemic) (Górecki and Babiak 2009). 
Treatment of late/haematogenous infection is more varied and generally 
dependant on the patient, anatomic location of infection and surgical 
preference. In general, one of the below treatments are offered: 
• 1-stage replacement 
• 2-stage replacement 
• Permanent removal of prosthesis 
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• Suppressive antimicrobial therapy 
 
Current literature suggests that 1-stage revision with cement and antibiotics 
controls infection in 83% of cases, whilst 2-stage replacement with cement and 
antibiotics controls infection in 91-97% of cases and is viewed by some as the 
gold standard (Callaghan, Katz et al. 1999, Buttaro, Pusso et al. 2005). 
Treatment is therefore controversial, and whilst infection may be more 
effectively controlled by 2-stage revision, the individual patient still requires 
two operations increasing overall operative risk. It must however be 
remembered that, as with most medical problems, prevention is the best 
strategy (Jahoda 2009). 
1.3 Bacteria and Biofilms 
Specific bacteria and biofilms associated with arthroplasty will now be 
discussed, in addition to current treatment strategies, the role of 
osseointegration and altered implant surface topography. 
1.3.1 Bacteria associated with arthroplasty 
Staphlococci are a genus of gram-positive bacteria and include around 40 
different species. Under the microscope they appear round (cocci) and form in 
grape-like clusters (Ryan and Ray 2004). The majority are found on the skin and 
mucous membranes of humans and other organisms, and can broadly be divided 
into their ability to produce coagulase, an enzyme causing blood clot formation 
(Rogers, Fey et al. 2009).  
S. epidermidis is coagulase negative species and is widely recognised as an 
opportunistic pathogen of foreign bodies, especially prosthetic cardiac valves 
(Blouse, Lathrop et al. 1978, Hammond and Stiver 1978, Christensen, Simpson et 
al. 1982), intravascular catheters (Bender and Hughes 1980, Gristina, Hobgood et 
al. 1987) and orthopaedic implants (Patterson and Brown 1972, Ainscow and 
Denham 1984, Ahnfelt, Herberts et al. 1990). In recent studies coagulase 
negative staphylococcus (CoNS) has been found to account for almost half of all 
TJA infections, of which S. epidermidis makes up almost 70%, meaning this is the 
causative organism in 32% of all orthopaedic implant-related infections 
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(Campoccia, Montanaro et al. 2006). Nosocomial infections represent the most 
frequent types of infection caused by S. epidermidis however in contrast to S. 
aureus these infections usually do not cause sepsis in non-compromised patients 
(Vuong and Otto 2002). The main reason for this being that S. epidermidis has 
only one primary toxin associated with it, the haemolytic peptide δ-toxin (often 
associated with necrotizing enterocolitis in neonates)(Overturf, Sherman et al. 
1990). This toxin causes lysis of erythrocytes by forming pores in the cytoplasmic 
membrane and is thought to be involved in the construction, growth and 
subsequent detachment of the biofilm (McKevitt, Bjornson et al. 1990). It is also 
suggested that the δ-toxin forms an inflammatory polypeptide which in turn 
modulates cytokine and nuclear factor κB expression in macrophages (Mehlin, 
Headley et al. 1999). As a result S. Epidermidis is usually associated with chronic 
infections, typically in the immunocompromised patient, or when foreign bodies 
such as implantable orthopaedic devices are involved. Given its relative non-
toxic nature, S. epidermidis relies heavily on its ability to form biofilms, 
specifically its adherence to surfaces (Vuong and Otto 2002). This biofilm 
forming ability is considered to be S. epidermidis’s main virulence factor (Raad, 
Alrahwan et al. 1998). Additionally, it also produces exoenzymes, primarily a 
metalloprotease and a cysteine protease, which have demonstrated an ability to 
degrade host matrix proteins and components of the immune system in vitro 
(Sloot, Thomas et al. 1992), thought to be through the actions of elastase 
(Teufel and Götz 1993). 
Virulence factor regulation is similar between S. epidermidis and S. aureus, with 
the accessory gene regulator (AGR) locus being key (Recsei, Kreiswirth et al. 
1986). This is a quorum-sensing system, thus the AGR-regulated target 
expression is cell-density dependant. In brief, when cell density is low, surface 
proteins are expressed allowing tissue colonisation. As cell density increases, 
AGR becomes active, surface protein production stops and extracellular 
exoenzymes and toxins are produced (Novick and Muir 1999). Other regulatory 
loci such as SAR and sigB have also been indicated (Cheung, Koomey et al. 1992, 
Deora, Tseng et al. 1997) and likely form a complicated network of regulatory 
loci that govern  virulence factors both in S. epidermidis and S. aureus (Kuroda, 
Ohta et al. 2001). 
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S. aureus is a coagulase positive organism and is an important nosocomial 
pathogen, able to cause a variety of human disease conditions. It is commonly 
found as part of the normal skin flora in the anterior nasal nares especially, with 
20% of the general population being long-term carriers (Kluytmans, Van Belkum 
et al. 1997). When cutaneous/mucous barriers are breached, significant 
infection can ensue ranging from simple cellulitis through to pneumonia, 
meningitis, bacteraemia and sepsis (Bowersox 1999). Campoccia et al (2006) 
found S. aureus to be the responsible organism for 34% of all orthopaedic 
implant-associated infections, constituting the chief causative organism 
(Campoccia, Montanaro et al. 2006). In comparison to S. epidermidis, S. aureus 
has a wide variety of toxins that improve its ability to colonise and cause 
disease, including haemolysins, nucleases, proteases, lipases and collagenases 
(Bernheimer and Bey 1986, Dinges, Orwin et al. 2000). In addition some strains 
are known to produce toxic shock syndrome toxin-1 (TSST-1) (Monday and 
Bohach 1999), staphylococcal enterotoxins (Bernheimer and Bey 1986), 
exfoliative toxins and leucocidin (Colin, Mazurier et al. 1994). Collectively these 
toxins are thought to affect the cells of the immune system, primarily inhibiting 
the host immune responses to S. aureus (Dinges, Orwin et al. 2000). More 
specifically TSST-1 and the staphylococcal enterotoxins are known as pyrogenic 
toxic superantigens (PTSAgs). In addition to S. aureus, Streptococcus pyogenes 
has also been found to produce these PTSAgs (Monday and Bohach 1999). This 
PTSAg group are known to enhance endotoxin lethality, with staphylococcal 
enterotoxins being potent emetic agents (Schlievert, Jablonski et al. 2000) and 
have an association with significant myocardial necrosis (Schwab, Watson et al. 
1955). TSST-1’s in comparison show an increased ability to cross the mucosal 
surfaces (Davis, Kremer et al. 2003) and increases the effect of endotoxin on 
renal tubular cells (Keane, Gekker et al. 1986). The exact causative mechanism 
for emesis is not fully understood, however it is thought to be an inflammatory 
response to staphylococcal enterotoxins, and symptoms have been correlated to 
the generation of a number of inflammatory mediators such as prostaglandin E2, 
leukotriene B4 and 5-hydroxyeicosatetraenoic acid (Jett, Neill et al. 1994). 
Ultimately these result in stimulation of the medullary emetic centre in the 
brain stem through vagal and sympathetic transmission (Dinges, Orwin et al. 
2000). Whilst usually self-limiting, if it is associated with toxic shock syndrome 
(TSS), morbidity is usually significantly higher. TSS is an acute, and sometimes 
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fatal, syndrome characterised by high fever, erythematous rash, hypotension, 
and multi-organ involvement (Davis, Chesney et al. 1980, Shands, Schmid et al. 
1980, Lee, Deringer et al. 1991, Davies and Geesey 1995). Acute respiratory 
distress syndrome and disseminated intravascular coagulation are common and 
potentially life threatening complications of TSS (Shands, Schmid et al. 1980, 
Arko, Rasheed et al. 1984). In addition, S. aureus is also known to produce a 
number of cytotoxic molecules, namely haemolysins and leukocidin. Of the 
haemolysins, Alpha-haemolysin has been researched most thoroughly and is 
common in a high percentage of S. aureus strains (Dinges, Orwin et al. 2000). It 
is dermonecrotic and neurotoxic and it thought to cause osmotic swelling by 
breaking down cell integrity and increasing intravascular permeability (Bhakdi, 
Bayley et al. 1996). Coded by the hla gene, alpha-haemolysin is one of the most 
potent cytotoxins, with levels as low as 1µg being lethal following intravenous 
injections in rabbits (Freer and Arbuthnoti 1982, Bhakdi, Bayley et al. 1996). 
Other cytotoxins such as beta, gamma and delta haemolysin and leucocidin are 
known to be involved with S. aureus, in particular immune response mediation, 
however, the exactly mechanisms are not fully understood (Dinges, Orwin et al. 
2000). 
1.3.2 The Biofilm 
Bacteria have been identified in fossils dating back over 4.5 billion years 
(Sochart 2012). Most research into bacterial infection was historically based on 
acute infection, which has now been largely combatted by the development of 
modern vaccines, antibiotics and infection control measures (Bjarnsholt 2013). In 
the 20th century these diseases have been supplemented by a new type of 
chronic infection, caused by bacteria growing in slime-enclosed aggregates 
known as biofilms. Biofilms were first described by Antonie Van Leeuwenhoek 
who examined the “animalcules” in the plaque on his own teeth in the 
seventeenth century (Donlan and Costerton 2002) and in the 1930-40’s  were 
described as ‘colonies in which microbes of different varieties and shapes 
congregate as they attach to some surface’(Heukelekian and Heller 1940, Tresse, 
de Wit et al. 2008). It is unlikely these scientists fully appreciated what they 
were describing or indeed what a profound difference biofilms would make to 
modern microbiology and medicine. It was not until the 1980’s when Costerton 
demonstrated the role of the biofilm in prosthetic joint infections (Sochart 
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2012). It has become increasingly clear, primarily through natural environmental 
studies, that biofilms are commonplace and consist of communities of sessile 
organisms embedded in a hydrated matrix of extracellular polymeric slime with 
polysaccharides, proteins (Costerton, Stewart et al. 1999) and nucleic acids 
(Fux, Stoodley et al. 2003). Biofilms were further recognised to prefer inert 
surfaces, such as stones in a stream, or indeed prosthetic implants and other 
medical devices (Costerton, Stewart et al. 1999). 
Biofilms are composed primarily and characteristically adhere to surfaces 
(Sochart 2012). A biofilm can contain one or more bacterial or fungal strains and 
species and can be defined by a number of characteristics (Costerton, Stewart et 
al. 1999, O'Toole, Kaplan et al. 2000, Fux, Stoodley et al. 2003). A biofilm is a 
community of bacterial cells that form a consortium that is surrounded and 
protected by a matrix produced and secreted by the bacteria. This 3D biofilm 
structure is a dynamic process and involves a series of co-ordinated molecular 
events, controlled primarily through quorum sensing and inter-bacterial 
communication (Fux, Stoodley et al. 2003). This extra-cellular matrix contains 
different extracellular polymeric substances (EPS) including proteins, DNA and 
polysaccharides. This can provide the biofilm with a protective coating, thus 
allowing the biofilm to withstand very high doses of particular antibiotics that 
would kill planktonic cells outright (Bjarnsholt 2013). In addition the biofilm 
allows a dramatic increase in tolerance to host defences providing the root of 
many bacterial infections (Fux, Stoodley et al. 2003). It is recognised that whilst 
antibiotic therapy typically reverses the symptoms caused by the release of 
planktonic cells from the biofilm, the biofilm itself remains alive and intact 
(Marrie, Nelligan et al. 1982). For this reason, biofilm infections are recognised 
to show recurring symptoms, after cycles of antibiotic therapy, until the sessile 
population is surgically removed (Lynch and Robertson 2008). Antibiotic 
resistance has been attributed to the restricted penetration of the anti-
microbial and host defences into biofilms, and recent studies suggest that 
resistant biofilm phenotypes are emerging (Xu, McFeters et al. 2000). It should 
also be noted that the bacterial colony must be adherent to a surface, either 
inert (Costerton, Stewart et al. 1999), or biological such as in bacterial 
endocarditis, cystic fibrosis (Hoiby, Ciofu et al. 2010), the gastrointestinal tract 
(Macfarlane and Dillon 2007) or oral mucosa (Dongari-Bagtzoglou 2008). 
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Biofilm formation takes place in several stages depicted in Figure 1-6. Bacterial 
adhesion is the first stage and relies on the surface of the biomaterial 
undergoing changes on its surface after implantation. This is known as surface 
conditioning and occurs through physical, chemical and electrostatic 
mechanisms (Sochart 2012). This is the critical stage, or ‘race to the surface’ 
which is essentially a battle between tissue cell integration and bacterial 
adhesion to the same surface (Gristina, Hobgood et al. 1987). On contact with 
the surface, bodily fluids immediately coat the implant with host materials, 
namely serum proteins and platelets (Neut, van Horn et al. 2003). This coating, 
as well as preventing an autoimmune reaction to the implant, allows bacterial 
adhesion. Bacterial attachment is facilitated by adhesins (organism specific cell 
surface proteins or lipoproteins) and bacterial aggregation occurs where they 
become encased in EPS to form what is known as a biofilm (Costerton, Stewart 
et al. 1999). It has been suggested that during this attachment phase, possibly 
after micro-colony formation, the transcription of specific genes is activated. 
Studies with P. aeruginosa have shown transcription of genes that are required 
for the synthesis of EPS are activated on attachment to a solid surface (Davies 
and Geesey 1995). This suggests that by merely attaching to a solid surface, 
bacteria are able to immediately start forming EPS, thus creating a protective 
environment to thrive. 
Once adhered and aggregated, bacteria begin to grow and enter the maturation 
phase. At this stage bacteria appear to develop coordinated social behaviour 
moving into differentiated micro-colonies. It is suggested that this gene 
expression and subsequent differentiation occurs through quorum sensing 
(Costerton, Stewart et al. 1999). This is a cell density-dependant control 
mechanism, such that when a critical bacterial density is reached, signalling 
molecules produced by the bacteria activate bacterial receptors and produce 
and release extracellular signals. This is a dedicated communication system that 
allows sharing of genetic information between bacteria by conjugation, 
transformation and transduction (Sochart 2012). This would go some way to 
explaining the development of antibiotic resistance in some biofilms.  
Finally the last stage of the biofilm cycle is detachment and dispersal of 
planktonic cells from biofilms. During this stage pieces of biofilm break away 
and are dispersed into surrounding fluid. This permits spread of the bacteria and 
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allows it to colonise new surfaces. Again it appears that this process is initiated 
by a chemical cue, much like biofilm maturation. Studies of P. aeruginosa have 
shown that biofilm detachment is a result of alginate digestion by alginase (Hay, 
Gatland et al. 2009). While many antimicrobial therapies target bacteria 
systemically, this is often after adhesion has occurred. This study focusses on 
prevention of bacterial adhesion as a strategy against TJA infection. Utilising 
modern molecular techniques it has become increasingly clear that if bacterial 
adhesion can be restricted, then the subsequent stages of development can be 
prevented, blocking biofilm production. Without a protective biofilm 
environment, bacteria are almost one hundred times more susceptible to 
antimicrobial treatment (Olson, Ceri et al. 2002), thus by preventing bacterial 
adhesion, arthroplasty infection could be treated more effectively and overall 
incidence drastically reduced. 
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Figure 1-6 The stages of Biofilm formation (Jahoda 2009) 
 
1.3.3 Biofilm treatment strategies 
Before treatment strategies can be discussed, our ability to diagnose chronic 
infections due to biofilm formation needs to be understood. As previously 
mentioned, acute infections are generally easy to diagnose and treat. The 
problem, specifically with orthopaedics, lies with diagnosing chronic or delayed 
infection. Routine sampling at present relies either on a wound swab or biopsy 
via needle aspiration or tissue sample. Clearly if a deep seated infection is 
present, the wound if often clean and dry and causes no concerns, therefore a 
swab if of no use. Equally with a biopsy, given the heterogeneous distribution of 
bacteria there is a risk that a biopsy may fail to contain any bacteria (Bjarnsholt 
2013). A diagnostic review by Trampuz and Zimmerli in 2005 suggested that a 
combination of laboratory, histopathology, microbiology and imaging achieves 
the highest sensitivity, specificity and accuracy for prosthetic joint replacement 
infection (Trampuz and Zimmerli 2005) (Table 2). 
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Investigation Comment Median 
Sensitivity 
Median 
Specificity 
References 
Laboratory Tests 
• C-Reactive 
Protein 
 
• Synovial Fluid 
 
• ESR 
 
Repeated increasing 
measurements post-
operatively 
Leukocyte count 
>1.7 x 109/l  
Differential >65% 
neutrophils  
Elevated 
 
95% 
 
 
97% 
 
 
 
83% 
 
90% 
 
 
98% 
 
 
 
90% 
 
(Widmer 
2001, 
Trampuz, 
Steckelberg 
et al. 2003, 
Trampuz and 
Zimmerli 
2005) 
Histopathology ≥1 to ≥10 neutrophils 
per high powered 
field, averaged over 
10 high powered 
fields  
 
82% 
 
96% 
 
(Athanasou, 
Pandey et al. 
1995, 
Widmer 
2001, 
Trampuz, 
Steckelberg 
et al. 2003, 
Trampuz and 
Zimmerli 
2005) 
Microbiology 
• Preoperative 
Aspiration 
• Intraoperative 
specimen 
• Sonication of 
implants 
 
Sterile, not on 
antibiotics 
Tissue Culture (Min. 
3-6 samples) 
Material cultured in 
laboratory 
 
86% 
 
99.6% 
 
78.5% 
 
92% 
 
86% 
 
98.8% 
 
(Atkins, 
Athanasou et 
al. 1998, 
Widmer 
2001, 
Trampuz, 
Piper et al. 
2007, Høiby, 
Bjarnsholt et 
al. 2015) 
Imaging 
• Nuclear 
Medicine 
 
Labelled WBC/IgG 
 
95.5% 
 
 
88% 
 
(Widmer 
2001, 
Trampuz and 
Zimmerli 
2005) 
Table 2 Adapted summary of diagnostic criteria for infected arthroplasty 
(Widmer 2001, Trampuz and Zimmerli 2005, Høiby, Bjarnsholt et al. 2015) 
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Even if a biofilm infection is diagnosed, the treatment is vastly different to that 
of an acute infection. Antibiotics may not penetrate the biofilm, leaving 
operative removal of the infected implant the only viable option followed by 
prolonged periods of combination antibiotic therapies (Høiby, Bjarnsholt et al. 
2010). Current research focuses on substances that destroy the biofilm matrix, 
such as disperin-B (Donelli, Francolini et al. 2007), or altering quorum sensing by 
quorum quenching enzymes (Dong and Zhang 2005). Other angles to the biofilm 
problem involve electromagnetic fields to enhance antibiotic activity or 
substances that cause ‘self-destruction’ of the biofilm (Sochart 2012). Although 
these methods may well prove beneficial, it is the authors belief, and it is 
widely recognised that, the most efficient means of combatting biofilm 
infections is to prevent infection in the first place (Bjarnsholt 2013). Whilst in 
normality the human skin acts as a barrier against bacterial invasion, this barrier 
is compromised by surgery and the insertion of implants. One aspect of 
prevention is therefore aimed at surgical technique and hygiene. The aseptic 
technique, first introduced by Joseph Lister, is of extreme importance. In 
addition the use of ultra-clean theatres with laminar flow, sterile instruments, 
garments and implants are paramount in the avoidance of contamination (Babb, 
Lynam et al. 1995, Chow and Yang 2004) and must be combined with 
administration of prophylactic antibiotics (Høiby, Bjarnsholt et al. 2010). 
As mentioned previously, the two main problems that contribute to arthroplasty 
revision are failure of bone-implant interface and arthroplasty infection. A great 
deal of research continues to look at improving the former, with titanium being 
used for implants due to its ability to form an oxide layer over the implant, thus 
improving biocompatibility and bioactivity (Wang, Ouyang et al. 2011). Despite 
this however, osseointegration is often not sufficient, resulting in mechanical 
instability and ultimately implant failure. Research at present is focusing on 
controlling this bone-implant interface and is aimed at producing a surface that 
is both osteoconducive (a surface that allows bone growth (Albrektsson and 
Johansson 2001)) and osseointegrative regardless of implantation site or bone 
quality (Puleo and Nanci 1999). It is certainly recognised that tissues act mainly 
with the outermost layers of an implant, in an area known as the ‘primary 
interaction zone’ which measures approximately 0.1-1nm in thickness (Kasemo 
1998). It would therefore be reasonable to assume that by altering this area, the 
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interactive ability of the implant, be it osseointegrative or its effect on bacterial 
adherence, may be altered.  
Osseoinduction was first described by Brånemark et al in 1977 (Branemark, 
Hansson et al. 1977) and defined by Albrektsson et al (1981) as direct contact 
between living bone and implant (at light microscope magnification) 
(Albrektsson, Brånemark et al. 1981). In the context of bone/implant 
interactions, osseointegration involves the recruitment of immature, 
undifferentiated mesenchymal stem cells and their subsequent stimulation to 
allow osteoblast development  (Albrektsson and Johansson 2001). This 
stimulation is dependent on the particular implant biomaterial, with metals such 
as copper and silver performing poorly in relation to osseointegration, whilst 
titanium is significantly more osseointegrative (Albrektsson, Brånemark et al. 
1981). Despite the widespread use of titanium, oral prosthetic studies have 
suggested that 17 years after implantation, average bony contact was only 70-
80% (Albrektsson, Eriksson et al. 1993). A great deal of research has therefore 
focussed on improving osseointegration by altering the implant surface. Perhaps 
the most publicised and commercially available coating is that of hydroxyapatite 
(HA) which is suggested to improve osseointegration (de Groot, Geesink et al. 
1987, Geesink, de Groot et al. 1987). HA provides a source of calcium and 
phosphate, similar to that of the host’s bone, which allows osteoblasts to form 
osteoid directly onto the HA surface coating increasing new bone formation and 
the bone/implant interface (Soballe 1993). Research into HA coating continues 
to evolve, with the integration of bioactive molecules and growth factors in an 
attempt to further improve implant longevity (Choi and Murphy 2010, Saran, 
Zhang et al. 2011, He, Huang et al. 2012).  
Biomimetic molecules such as collagen have been shown to improve implant 
integration (Rammelt, Illert et al. 2006, Mathews, Bhonde et al. 2011), whilst 
coating implants with growth factors improve their ability to modulate cell 
functions such as enhancing stem cell differentiation and decreasing 
inflammation (Liu, de Groot et al. 2005, Macdonald, Samuel et al. 2011). Smaller 
molecules, such as peptides, derived from protein molecules, have also been 
shown to increase cellular functions such as adhesion and bone formation 
(Auernheimer, Zukowski et al. 2005, Wojtowicz, Shekaran et al. 2010). Whilst 
Ch. 1 Introduction 
 24 
the encouragement of osseointegration is of clear importance to implant 
survival, the mitigation of infection must also be addressed. 
Infection resistant coatings can be categorized as passive or active. Passive 
coatings do not release bactericidal agents to the surrounding tissues, while 
active coatings release pre-incorporated bactericidal agents such as antibiotics, 
antiseptics, silver ions and growth factors/chemokines/peptides to down 
regulate infection (Goodman, Yao et al. 2013).  Current arthroplasty practice 
involves the routine administration of prophylactic antibiotics and, depending on 
implant, the use of antibiotic loaded bone cement. First popularised by Buchholz 
et al (1970) the incorporation of antibiotics into PMMA cement can reduce deep 
infection rates in conjunction with systemic antibiotics (Engesaeter, Lie et al. 
2003). The use of antibiotic loaded bone cement has decreased, particularly in 
the United States, with the increased use of cementless implants worldwide 
(Goodman, Yao et al. 2013). This provides an opportunity for the development of 
new antibacterial technologies.  Such advances include the incorporation of 
broad-spectrum antibiotics such as gentamicin into HA coatings on titanium 
implants, significantly reducing implant related infection (Alt, Bitschnau et al. 
2006). This however relates to acute implant infection, with 80-90% of the 
antibiotics being released within the first 60 minutes following implantation, 
therefore their role in chronic infection remains unclear (Alt, Bitschnau et al. 
2006). An optimal antibiotic delivery system should release antibiotics at an 
optimal bactericidal level, for a sufficiently long period of time and then stop to 
prevent antibacterial resistance and tissue integration side effects (Antoci, 
Adams et al. 2007). Clearly this requires a complex and advanced implant 
coating that currently is not available.  
The surface characteristics of implants, however, can be altered to provide a 
passive approach to preventing infection. Modification of the properties of the 
implant surface provides a relatively simple way to prevent bacterial adhesion. 
Increasing surface ‘wetability’ through UV light exposure (Yu, Ho et al. 2003, 
Gallardo-Moreno, Pacha-Olivenza et al. 2009), hydrophilic PMMA implant 
coatings and protein resistant polyethylene glycol have been applied to titanium 
implants and reduced bacterial adhesion (Harris, Tosatti et al. 2004, Del Curto, 
Brunella et al. 2005). There is however debate as to whether these surface 
alterations impair osseointegration.  
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1.3.4 Biofilms and Topography 
Whilst the above advances are undoubtedly important, the physical aspect of the 
material surface in relation to bacterial adhesion is an area of research that has 
long been neglected. When looking at bacteria, this material topography is 
assessed at the nanometre scale. Recent research has shown that alterations in 
the surface topography at the nanoscale can have major effects on cell 
behaviour (McMurray, Gadegaard et al. 2011), bacterial adhesion (Xu and 
Siedlecki 2012) and ultimately long term implant survival (Sjöström, Brydone et 
al. 2013). Dental research has shown that particular nanopatterns show 
biocompatible responses and are capable of inducing osteoblastic cell adhesion, 
spreading and propagation (Pelaez-Vargas, Gallego-Perez et al. 2011). Research 
regarding bacterial adhesion has shown that submicron surface textures on 
polyurethane can significantly reduce bacterial adhesion when looking at S. 
aureus and S. epidermidis, with a subsequent reduction in biofilm formation (Xu 
and Siedlecki 2012). Due to challenges associated with fabricating surfaces at 
the nanoscale, the majority of research to date has been performed on surfaces 
other than titanium. This project therefore focuses on bacterial adhesion, and 
subsequent biofilm formation of nanofabricated titanium. It is postulated that by 
controlling particular nanosurface parameters, bacterial adhesion can be 
effectively regulated. 
1.3.5 Bacterial metabolomics 
While multiple mechanical theories as to the mechanism behind bacterial 
adhesion exist (De Beer, Stoodley et al. 1994, Fuchs, Haritopoulou et al. 1996, 
Baty, Eastburn et al. 2000, Edwards, Bond et al. 2000), it has been suggested 
that adhesion is mediated by surface proteins (Hussain, Herrmann et al. 1997), 
extracellular proteins (Heilmann, Schweitzer et al. 1996), adhesins (McKenney, 
Hübner et al. 1998) and autolysins (Heilmann and Götz 1998) to name a few. The 
metabolomic pathways associated with such compounds and therefore bacterial 
adhesion remains relatively under-researched.  
Metabolomics is defined as ‘the quantitative measurement of the dynamic multi-
parametric metabolic response of living systems to pathophysiological stimuli or 
genetic modification’ (Nicholson, Lindon et al. 1999). Metabolomics is the study 
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of a complete complement of small molecules (known as metabolites) within a 
system, known as the metabolome. The metabolome was first described by 
Oliver et al in 1998 (Oliver, Winson et al. 1998) whilst studying the yeast 
genome, and resultant metabolomics development is often referred to as 
metabonomics (Nicholson, Lindon et al. 1999) or metabolic profiling (Niwa 1986) 
by some groups. The ability to provide a ‘snap-shot’ of cell metabolism is 
emerging as a useful tool across a multitude of disciplines, ranging from plant 
physiology to human disease, nutrition and drug discovery, but has only become 
possible as a result of recent technological breakthroughs in small molecule 
separation and identification (Wishart 2008).  
Stable isotope labelling allows the targeting of specific compounds that are 
predicted to be involved in specific metabolomic pathways, and relies on the 
incorporation of labelled isotopes (such as 13C) into metabolite pools 
(Birkemeyer, Luedemann et al. 2005). These compounds can subsequently be 
traced ‘downstream’, highlighting any specific pathways demonstrating 
increased metabolic activity. Another equally important aspect of metabolomics 
is a compiled database containing descriptive and spectral information of all 
constituent chemicals found in different metabolomes (Smith, O'Maille et al. 
2005, Cotter, Maer et al. 2006, Moco, Bino et al. 2006, Wishart, Tzur et al. 
2007). The relatively recent production and widespread availability of such 
databases has allowed the detection and characterisation of multiple 
metabolomes in a matter of minutes (Dunn, Bailey et al. 2005, Moco, Bino et al. 
2006, Wishart 2008). 
Currently bacterial metabolomics has focused mainly on the classification 
(Hettick, Green et al. 2008) and understanding of normal bacterial metabolism. 
Schaub et al (2008) found altered glycolysis dynamics under differing growth 
rates and glucose availability in E. coli (Schaub and Reuss 2008), whilst Koek et 
al (2006) found a time-related progression of metabolites with bacterial growth 
(Koek, Muilwijk et al. 2006). While interactions between surface topography and 
bacterial adhesion are documented, the effects of targeting bacterial 
metabolism therapeutically are not and remain a novel area of research in 
metabolomics and thus an additional focus of this study. 
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1.4 Hypothesis 
It is hypothesised that by altering the surface topography at the nanometre 
level, bacterial adhesion can be altered. This thesis therefore aims to compare 
bacterial adhesion on different nanopatterned topographies, both through 
quantification and imaging. Metabolomic analysis will provide valuable 
information relating to bacterial adhesion pathways and therefore allow specific 
therapeutic targeting.  
Objectives that need to be overcome include biofilm growth optimisation, 
reproducibility of results, and factors such as incubation time, temperatures, 
growth phase application to surfaces and culture densities will have to be 
addressed. Additionally, a novel method for identifying upregulated adhesion 
metabolites and pathways is proposed. Expected problems include labelled 
compounds incorporation, metabolomics sample preparation and associated 
analysis. These issues will be addressed by utilising and adapting similar 
methodologies to those described by Birkemeyer et al (2005) and sample 
preparation to that of Stipetic et al (2015) (Birkemeyer, Luedemann et al. 2005, 
Stipetic, Hamilton et al. 2015, Stipetic, Dalby et al. 2016). 
By overcoming the objectives above, this research aims to test the hypothesis 
that different nanosurfaces affect bacterial adhesion and that targeted 
therapeutic metabolomics can directly inhibit bacterial adhesion pathways. 
Ultimately this would be of benefit to the patient, the NHS and society and 
provide a new wave of orthopaedic implant combined with targeted bacterial 
inhibition at the metabolomic level.  
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2.1 Introduction 
Adhesion and subsequent biofilm growth of both S. aureus and S. epidermidis is 
complex and influenced by numerous well-defined virulence factors. Virtually 
any surface can be colonised by bacteria, whether biotic or abiotic and includes 
all biomaterials (Dunne 2002). The process of bacterial attachment, as outlined 
in Chapter 1, and thus subsequent biofilm formation is dictated by a number of 
different variables (Dunne 2002), which must be considered when optimising 
bacterial adhesion in vitro. 
Principally, for adhesion to occur both the bacteria and surface must come into 
close contact. This critical proximity has been suggested to be around 1nm 
(Dunne 2002), however, proximity is not the only factor involved in adhesion. It 
has been shown to be dependent on a variety of different forces that exist 
between the inert surface and bacteria (Oliveira 1992). These are primarily Van 
der Waals attraction forces, electrostatic forces and hydrophobic interactions. 
Van der Waals forces are usually attractive and act over a relatively large 
separation distance (<50nm) (Fletcher 1996), but are relatively weak (Busscher, 
Cowan et al. 1992). In comparison electrostatic forces work at a much closer 
separation distance (10-20nm) and opposing surfaces must have opposite net 
surface charges to allow attraction. When considering bacteria and a potential 
attachment surface, the net surface charges are often negative, resulting in 
repulsion and prevention of adhesion (Carpentier and Cerf 1993, Fletcher 1996). 
In vitro this repulsion force is overcome by sufficient electrolyte concentrations, 
thus increasing the ionic strength of the medium and eliminating the 
electrostatic repulsion barrier (Fletcher and Loeb 1979). The most controversial 
force affecting bacterial adhesion is that of hydrophobicity. A number of studies 
have found that adhesion is directly related to surface hydrophobicity, with 
increased quantity (Fletcher and Loeb 1979, Paul and Loeb 1983), rate (Paul and 
Loeb 1983) and strength (Rijnaarts, Norde et al. 1993) of bacterial attachment 
occurring with hydrophobic surface forces. In contrast, however, other studies 
have observed no difference in bacterial adhesion when comparing hydrophobic 
and hydrophilic surfaces (Pedersen 1990, Busscher, Cowan et al. 1992). It should 
be recognised however, that in vitro, primary contact usually occurs between an 
 Ch.2 Staphylococcal Biofilm Growth Optimisation 
 30 
organism and a conditioned surface. This surface conditioning can significantly 
affect surface hydrophobicity and therefore adhesion (An, Dickinson et al. 2000, 
Dunne 2002). Any material surface exposed to an aqueous medium will almost 
immediately become conditioned or coated by polymers from that medium, 
which will then affect the rate and extent of microbial attachment (Donlan 
2002). First described by Loeb et al (1975) these conditioned films are found to 
form within minutes of exposure and are found both in the natural environment 
(George I and Rex A 1975) and bodily secretions such as blood, tears, urine, 
saliva and intravascular fluid (Sand 1997). Certainly, Wang and colleagues (1995) 
study on S. epidermidis adhesion demonstrated increased adhesion to 
polyethylene discs in the presence of surface-activated platelets (Wang, 
Anderson et al. 1995). Successive studies have shown plasma protein treated 
PMMA increases bacterial adhesion (Herrmann, Vaudaux et al. 1988). The above-
mentioned factors are widely recognised as the first stage of adhesion (Wang, 
Anderson et al. 1995, Fletcher 1996, Sand 1997, Dunne 2002), the longevity of 
which is dependent on the sum total of these variables. 
The second stage of adhesion is the ‘anchoring’ or ‘locking’ phase, and this 
relates to binding between specific adhesins and the surface (Dunne 2002). This 
represents irreversible bacterial attachment to a surface and is usually regulated 
at a transcriptional level (An, Dickinson et al. 2000). S. epidermidis is known to 
produce a polysaccharide intracellular adhesion (PIA), allowing for cell-to-cell 
adhesion and subsequent biofilm formation (Heilmann, Gerke et al. 1996, 
Heilmann, Schweitzer et al. 1996, Heilmann and Götz 1998), while S. aureus 
possess designated microbial surface components recognising adhesive matrix 
molecules (MSCRAMM), which are thought to play a major role in adhesion (Lowy 
1998).  
In addition to understanding bacterial adhesion, culture conditions are also 
important in bacterial growth optimisation. A multitude of different growth 
media’s are available for bacterial culture (Fletcher 1976, Christensen, Simpson 
et al. 1982, Park, Kim et al. 1998, Allan, Newman et al. 2001, Vieira and Nahas 
2005). As a general rule, growth media must contain a source of energy, carbon, 
nitrogen and minerals all of which are required bacterial growth and metabolism 
(Fred and Waksman 1928). The addition of a standardised bacterial 
concentration is also an important factor to consider, when discussing bacterial 
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growth, based on optical densities (OD), as this remains proportional to bacterial 
density (Monod 1949). Whilst providing a representation of bacterial 
concentration suitable for standardisation, this method does not provide an 
exact quantification. Quantification based on colony forming units (CFU) is a 
method used to estimate the number of viable bacteria or fungal cells in a 
sample. It is essentially a visual representation of bacterial growth, and requires 
each colony to be counted to provide a result. Whilst relatively simple to carry 
out, this method is time consuming and cannot ascertain whether a colony arose 
from one cell or a group of cells. For this reason, this method often results in an 
underestimation of bacteria (Parkinson, Gray et al. 1971). This is certainly likely 
to be the case with S. aureus and S. epidermidis, as they are both known to 
grow in clusters rather than homogenous planktonic cells (Goldman and Green 
2008). In comparison, a real-time polymerase chain reaction (qPCR) can be used 
to amplify and simultaneously quantify targeted bacterial DNA. Currently, qPCR 
is recognised by some as the quantification method of choice for the detection 
and quantification of microorgansims (Postollec, Falentin et al. 2011). It is 
quicker, more sensitive and more specific than culture based methods and does 
not carry the associated problems (Nolan, Hands et al. 2006). qPCR techniques 
have been described extensively (Heid, Stevens et al. 1996, Kubista, Andrade et 
al. 2006). In brief, qPCR consists of a succession of amplification cycles resulting 
in an exponential increase of DNA amplification products that can be monitored 
at every cycle using a fluorescent reporter. Fluorescence values obtained from 
each amplified product are recorded throughout the cycled reaction. There is an 
inverse relationship between the amount of DNA and the cycle number, thus a 
higher amount of DNA present at the beginning of the reaction, correlates to a 
fewer number of cycles being required to reach the cycle threshold (Ct). The Ct 
value is a level at which the fluorescence measured is statistically higher than 
background readings (Gibson, Heid et al. 1996), and is found during the 
exponential phase of amplification (Higuchi, Fockler et al. 1993). This study will 
utilise both methods described above to quantify bacteria. 
Accurate bacterial quantification also relies on adequate bacterial removal from 
a surface. While bacteria in liquids are relatively easy to quantify via the 
methods described above, bacteria attached to a surface are somewhat more 
troublesome. Explanted prostheses can be sonicated and the resultant fluid used 
 Ch.2 Staphylococcal Biofilm Growth Optimisation 
 32 
for quantitative analysis and culture (Monsen, Lövgren et al. 2009). Ultrasound 
disrupts the bacterial biofilm on the prosthetic material and when used as an 
addition to conventional culture, has been shown to improve the sensitivity of 
prosthetic joint infection microbiological diagnosis (Trampuz, Piper et al. 2007, 
Piper, Jacobson et al. 2009). This technique will therefore be utilised in this 
study. 
2.2 Chapter Aims 
It was the hypothesis of this study that surface property impacts the differential 
ability of staphylococci species to adhere. Therefore, the aim of this initial pilot 
investigation was to undertake optimisation experiments to define conditions 
and media for qualitative and quantitative assessment of staphylococcal 
adhesion upon biologically important substrates in downstream analyses. Work 
from this chapter has been published in: 
Hansom D et al THE EFFECTS OF NANOPATTERN SURFACE TECHNOLOGY ON 
ORTHOPAEDIC JOINT REPLACEMENT INFECTION. Bone & Joint Journal 
Orthopaedic Proceedings Supplement, 2015. 97-B(SUPP 3): p. 2. 
Work from this chapter has been presented at the following conferences: 
Hansom D, Tsimbouri M, Ramage G, Burgess K, Dalby M, Meek D and Clarke J. 
‘Nano-topographical modulation of cells and bacteria for next generation 
orthopaedic implants.’ Centre of Cell Engineering – Glasgow Orthopaedic 
Research Initiative, December 2014. 
Hansom D, Burgess K, Meek D, Clarke J, Ramage G. ‘The effects of nanopattern 
surface technology on orthopaedic joint replacement.’ Glasgow Meeting of 
Orthopaedic research, March 2015. 
Hansom D, Burgess K, Meek D, Clarke J, Ramage G ‘Nano-topographical 
modulation of cells and bacteria for next generation orthopaedic implants.’ El-
Minia University Hospital Scientific Day, Egypt, February 2015. 
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Hansom D, Burgess K, Gadengaard N, Millar N, Clarke J & Ramage G. ‘The 
effects of nanopattern surface technology on orthopaedic joint replacement.’ 
European Federation of National Associations of Orthopaedics and Traumatology, 
June 2016. 
Hansom D, Burgess K, Gadengaard N, Millar N, Clarke J & Ramage G. ‘The 
effects of nanopattern surface technology on orthopaedic joint replacement.’ 
British Orthopaedic Research Society, September 2016. 
2.3 Materials and Methods 
2.3.1 Bacterial Culture and Standardisation 
2.3.1.1 Staphylococcal strain collection 
Four different strains staphylococci were used in this study. S. aureus Newmans 
strain (Duthie and Lorenz 1952), an orthopaedic clinical isolate from the 
Southern General Hospital, Glasgow (Stipetic, Hamilton et al. 2015)), NCTC 
11047, and one well characterised biofilm forming strain of S. epidermidis 
(RP62A - ATCC 35984 (Gill, Fouts et al. 2005)). The clinical isolate was selected 
based on a positive hip aspirate obtained in theatre of a THR in a 75-year-old 
female. All strains were stored in the culture collection facility at the University 
of Glasgow Dental School at -80oC. These were maintained for in vitro 
experiments by streaking for single colonies onto Luria Bertoni (LB) agar (Vitko 
and Richardson 2013) and incubating for 24 h at 37oC, after which time growth 
was visually confirmed. Plates were stored intermittently at 4oC until required. 
A loopful of each isolate was inoculated into 10mL of tryptic soy broth (TSB) 
solution (casein peptone 17 g/L, dipotassium hydrogen phosphate 2.5 g/L, 
glucose 2.5 g/L, sodium chloride 5 g/L, Soya peptone 3 g/L [Sigma-Aldrich, 
Dorset, UK]) and placed in an orbital shaking incubator at 150rpm at 37oC 
overnight.  
2.3.1.2 Bacterial standardisation  
Following overnight growth, the samples were washed by centrifugation at 
3000rpm for 5 min. Supernatant was discarded and the pellet washed with 10ml 
of phosphate buffered saline (PBS [Sigma-Aldrich, Dorset, UK]). This was 
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centrifuged for a further 5 min at 3000rpm, after which the supernatant was 
removed and the pellet re-suspended in PBS. This was then vortex mixed to 
ensure homogenous sample mixing, and the optical density 590nm (OD590) 
prepared. All samples were standardised to an OD590 of 0.6 = 1x108 cfu/ml. 
These samples were then further diluted 100-fold in appropriate growth medium 
(TSB, Brain heart infusion [BHI], Dulbecco’s modified eagle medium [D-MEM], 
DMEM + supplements [10% foetal calf serum (FCS), 1% L-Glutamine, 1% sodium 
pyruvate and 1% non-essential amino acids] and FCS) to obtain a bacterial 
concentration of 1x106 cfu/ml. Different FCS concentrations were used to 
ascertain optimal bacterial growth, and therefore biofilm formation (10%, 25%, 
50% and 75%). Media selection was based on a range on growth conditions 
currently being used in different laboratories (Tranter, Tassou et al. 1993, 
Yarwood, Bartels et al. 2004). 
2.3.1.3 Growth kinetics and optimal media selection 
Following standardisation, 200µL of each sample was added to defined wells in a 
pre-sterilised, polystyrene 96-well, flat bottomed microtitre plate (Corning 
incorporated, NY, USA). The plate was incubated at 37oC for 24h with an OD590 
read every hour, followed by shaking at 100rpm for 30 sec (FLUOstar Omega, 
BMG labtech). Negative controls containing no organisms were included for each 
growth media, and all testing was carried out in triplicate on three separate 
occasions.  
2.3.2 DNA extraction and PCR analysis 
2.3.2.1 Bacterial DNA extraction 
Following standardisation (2.3.1), one ml of overnight bacterial culture was 
transferred to a 1.5 mL microfuge tube and centrifuged at 13,000 rpm for 10 min 
to pellet each sample. DNA was subsequently extracted using the MasterPure 
Gram Positive DNA Purification Kit (Epicentre®, Cambridge, UK). The 
supernatant was discarded and 150μL of TE Buffer (10mM Tris-HCL [pH 7.5], 1mM 
EDTA) was added to each sample to re-suspend the pellet and 1μL of lysozyme 
was added to break down the bacterial cells. Samples were incubated at 37°C 
for 2 h. Next, a cocktail containing 1μL proteinase K (50μg/mL) and 150μL Gram 
positive cell lysis solution was added to each sample, mixed thoroughly and 
 Ch.2 Staphylococcal Biofilm Growth Optimisation 
 35 
incubated at 75°C for 15 min. Samples were allowed to cool to 37°C and then 
stored on ice for 5 min before the DNA precipitation stage. To each lysed 
sample, 175μL of MPC protein precipitation reagent was added and vortexed for 
10 sec. Samples were then centrifuged at 13,000 rpm for 10 min at 4°C with the 
resultant supernatant transferred to a clean microfuge tube with 1μL of RNase A 
(5μg/mL). All samples were incubated at 37°C for 30 min and 500μL of 
isopropanol added to each supernatant, which were then mixed by inverting 
each tube. The DNA was pelleted by centrifugation at 13,000 rpm for 10 min at 
4°C. The pellet was washed with 70% ethanol and the DNA pellet was re-
suspended in 35μL of TE buffer. 
2.3.2.2 Nucleic acid quantification 
Nucleic acid quantification was performed using the NanoDropTM ND-100 
spectrophotometer (Labtech International, Ringmer, East Sussex, UK). Before 
the DNA was quantified, TE buffer was used as a reference and concentrations 
recorded in ng/μL. Samples with a 260/280nm ratio of 1.8-2.2 were accepted as 
high quality and used for PCR reactions. DNA was stored at -20oC until required. 
2.3.2.3 Bacterial Quantification using DNA qPCR and standard curve 
production. 
One μL of extracted DNA, as outlined in section 2.3.2.1, was added to a 
mastermix containing 10μL SYBR® GreenER™ (Invitrogen, Paisley, UK), 7μL of 
HyClone, nuclease free deionized distilled molecular biology grade water and 
1μL of 10μM forward/reverse primers for S. aureus and 16S primers for S. 
epidermidis (Invitrogen, Paisley, UK) (Marchesi, Sato et al. 1998). Primers were 
chosen based on their known locus and ability to identify the selected bacteria. 
The sequences for each primer set used are shown in Table 3. 
Target Primer sequence (5’-3’) 
S. aureus (SAR0134) 
F – ATTTGGTCCCAGTGGTGTGGGTAT 
R – GCTGTGACAATTGCCGTTTGTCGT 
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S. epidermidis (16S) 
F – GGGCGGGGTACAAGGC 
R – CAGGCCTAACACATGCAAGTC 
Table 3 S. epidermidis and S. aureus 16S primer sequences 
 
All reactions were carried out in 96 well plates and sealed using caps (Agilent 
Technologies, Cambridge, UK). All samples were centrifuged to remove any air 
bubbles before qPCR was carried out. Three independent replicates were 
analysed in triplicate using an Applied Biosystems Step One Plus Quantitative 
PCR machine and Step One software (Foster City, California 94404, USA) 
(Biosystems 2010). The thermal profile consisted of 50°C for 2 min to allow for 
DNA polymerase activation. This was followed by 40 amplification cycles of 95°C 
denaturation for 15 sec and 60°C annealing for 60 sec. A non-template control 
(NTC) replacing DNA with sterile water was included to rule out the presence of 
contamination. The cycle threshold (Ct) was set automatically and Ct values for 
all samples of interest were used for the quantification of bacteria. Ct values 
were used as they allowed comparative analysis.  Quantification was carried out 
by standardising each bacterial species to 1×108 CFU/mL followed by five-fold 
bacterial dilutions prepared ranging from 1×106 to 1×108 CFU/mL and finally DNA 
extraction and qPCR as described in section 2.3.2.1. Standard curves were 
constructed by plotting the Ct value against the equivalent log10 of the DNA 
concentration allowing unknown bacterial counts to be quantified. Each dilution 
of DNA was assessed in triplicate for each primer set. Trend lines were applied 
to all data sets and the R2 value was used to assess how well the trend line fitted 
and the fraction of variance. An R2 value of 1 represents a perfect fit between 
the trend line and the data points, and R2 value of 0 represents no relationship. 
Only trend lines with a linear association of above 0.97 were deemed acceptable 
for inclusion in this study. 
2.3.3 Biofilm Optimisation 
2.3.3.1 Bacterial incubation optimisation 
Standardised bacteria (2.3.1.2) in DMEM + Supplements were grown on 13mm 
plastic cover slips (Thermanox®, Rochester, NY, USA) in a 24 well plate for 30, 
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60 and 90 min time periods. Cover slips were used as Ti nanopattern and control 
surfaces were in limited supply, therefore all optimisation experiments were 
carried out on readily available materials.500μL of each bacterial sample was 
added to each well and the plates were incubated in a gentle shaking incubator 
at 37oC for the allotted time frame. Following incubation, supernatant was 
removed and the coverslips were washed in PBS twice and sonicated for 10 min 
in 5ml of PBS. Each sample was then transferred to a 1.5ml microfuge tube and 
centrifuged at 10,000rpm for 8 min. The resultant supernatant was removed and 
the remaining pellet re-suspended in 150μL of TE buffer. DNA extraction and 
qPCR was then performed as described in section 2.3.2.3. This experiment was 
conducted in triplicate and repeated three times. 
2.3.3.2 DNA extraction optimisation 
All samples were prepared following standardised techniques described in 
section 2.3.1. The first stages of DNA extraction were performed as per section 
2.3.2.1 and different lysozyme incubation times were implemented (60, 120, 180 
and 240 min). The standard DNA extraction and quantification protocol was 
subsequently followed (sections 2.3.2.1 and 2.3.2.3). This allowed bacterial DNA 
quantification values to be obtained for different lysozyme incubation periods. 
Each experiment was carried out in triplicate and repeated 3 times. 
2.3.4 Statistical Analysis 
Graph production and statistical analysis were performed using GraphPad prism 
software (version 4; La Jolla, CA, USA). One way analysis of variance (ANOVA) 
was used to investigate significant differences between independent groups. If 
ANOVA revealed a statistical significance, a Dunnett’s multiple comparison test 
was performed to determine statistical significance between groups. Statistical 
significance was achieved if P<0.05. Standard curve production, linear trend-line 
equations and R2 values were achieved using Microsoft Excel, Microsoft 
Cooperation© (version 14.0.7128.500 32-Bit, 2010). 
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2.4 Results 
2.4.1 Growth Kinetics 
First, the growth kinetics of different clinical strains was examined. For all S. 
aureus strains tested, bacterial growth was noted to be significantly higher 
(P<0.05) in BHI, TSB and DMEM + supplements when compared to all FCS media 
(10%, 25%, 50% and 75%) (Figure 2-1). The clinical and Newman’s strains were 
found to grow significantly better (P<0.05) in BHI, TSB and DMEM + supplements 
when compared to DMEM alone. The NCTC strain (Figure 2-1 [C]) was found to 
grow significantly better in BHI (P<0.05), but not TSB or DMEM + supplements 
when compared to DMEM alone. Of the media tested we focused on DMEM + 
supplements as this has been used extensively in cell culture experiments 
(Coelho, Cabral et al. 2000, Mandel and Tas 2010, Tsimbouri, McMurray et al. 
2012, Tsimbouri, Gadegaard et al. 2014) and allows for future cell co-culture 
studies. No significant difference was found between bacterial growth in all 
strains when comparing DMEM + supplements and TSB media. When comparing 
different bacterial strains, the Newman’s strain grew significantly better in 
DMEM + supplements when compared to the other S. aureus strains. 
The biofilm control strain S. epidermidis was found to grow significantly better 
in TSB, BHI and DMEM + supplements when compared to 10%, 50% and 75% FCS 
medias (P<0.001) and 25% FCS media (P<0.01). Growth was also significantly 
better in TSB, BHI and DMEM + supplements when compared to DMEM alone 
(P<0.001) (Figure 2-1 [D]).  
As illustrated, the optimal growth conditions that were clinically representative 
and reproducible were that of the Newman’s strain in DMEM + supplements 
media. This was therefore the bacterial strain and media used for all subsequent 
experiments. 
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Figure 2-1 Bacterial growth curves. 
All bacterial species and strains were standardised and grown in different media for a period of 24 h. (A) – Clinical strain. Growth was significantly 
better in TSB, BHI and DMEM + supplements when compared to all FCS concentration and DMEM (#P<0.05). (B) – Newman strain. Growth was 
significantly better in TSB, BHI and DMEM + supplements when compared to all FCS concentration and DMEM (#P<0.05). (C) – NCTC strain. Growth was 
significantly better in TSB, BHI and DMEM + supplements when compared to all FCS concentration and BHI when compared to DMEM (#P<0. 05). (D) – S. 
epidermidis. Growth was significantly better in TSB, BHI and DMEM + supplements when compared to 10%, 50% and 75% FCS concentration and DMEM 
(##P<0.001). Growth was significantly better in DMEM + supplements when compared to 25% FCS (#P<0.01).
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2.4.2 Standard curve production 
Following the method described in section 2.3.2.3, standard curves were 
produced for all bacterial strains (Figure 2-2). The R2 value was used to assess 
the fit of the trend line compared to the data points. All trend lines reached 
inclusion criteria and demonstrated a R2 value of >0.97.
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Figure 2-2 Standard curves for all bacterial species and strains. 
Overnight cultures were standardised, and subsequently underwent 5-fold dilutions as per section 2.3.2.3. DNA was then extracted and 
qPCR performed as described in section 2.3.2.1. Average  of all Ct values were plotted against the equivalent log10 of the DNA 
concentration and a linear trend line applied. The line equations allowed unknown bacterial counts to be quantified based on a single Ct 
reading. Each dilution of DNA was assessed in triplicate and repeated 3 times. 
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2.4.3 Optimal Bacterial Incubation  
DNA extraction and qPCR (2.3.2) was used to identify the initial exponential 
increase in bacterial DNA concentration, illustrating the initial stages of biofilm 
development across all S. aureus strains. After 90 min incubation, bacterial 
concentration was found to be significantly higher when compared to 60 min 
(P<0.01) and 30 min (P<0.001) incubations in Newman’s and clinical strains. 
There was no significant difference in bacterial concentration between 30 and 
60 min incubations across all strains. 60 min was therefore used as the optimal 
incubation to isolate the adhesion phase of bacterial growth time (Figure 2-3), 
before exponential bacterial growth. 
 
Figure 2-3 Optimised bacterial Incubation time. 
S. aureus strains (NCTC, Newman’s and clinical) were grown for 30, 60 and 90 
min in DMEM + supplements media. Three replicates for each strain were used 
and carried out on 3 separate occasions. Data represents mean ± SEM. Significant 
differences were observed when comparing 90 min incubations to both 30 and 60 
min incubations in Newman’s and clinical (Stipetic, Hamilton et al. 2015)  S. 
aureus  strains. (##P<0.001, #P<0.05). No significant difference was noted 
between 30 and 60 min incubations in all strains. 
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2.4.4 Lysozyme incubation optimisation 
Lysozyme incubation time was analysed in relation to the Newman’s strain only 
(Figure 2-4). An incubation time of 120 min resulted in significantly more 
bacterial DNA being extracted when compared to 60 (P<0.001), 180 and 240 min 
(P<0.01). No significant difference was found between 60, 180 and 240 min. The 
optimal lysozyme incubation time of 120 min was used for all subsequent DNA 
extractions. 
 
Figure 2-4 Optimal lysozyme incubation time. 
Newman’s strain was grown 60 min in DMEM + supplements media. Three 
replicates for each sample were used and carried out on 3 separate occasions. 
Data represents mean ± SEM. Significant differences were observed when 
comparing 120 min incubations to both 60 (##P<0.001) and 180 and 240 min 
incubations (#P<0.01). No significant difference was noted between 60, 180 and 
240 min incubations. 
 
2.5 Discussion 
Implantable medical devices or biomaterials continue to be used extensively in 
modern medicine, specifically in orthopaedics (Charnley 1960, Ratner 2004, 
Gomez and Morcuende 2005, Kurtz, Ong et al. 2007). Orthopaedic implant 
infection represents a significant arthroplasty complication (Ainscow and 
Denham 1984, Ahnfelt, Herberts et al. 1990), with S. aureus and S. epidermidis 
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constituting up to 60% of all confirmed arthroplasty infections (Trampuz and 
Widmer 2006). Whilst a great deal of literature highlights the importance of 
these bacterial species in orthopaedic infections (Garvin, Hinrichs et al. 1999, 
Campoccia, Montanaro et al. 2006, Nickinson, Board et al. 2010), methods of 
standardising and optimising staphylococcal biofilm growth and quantification 
vary greatly (Bergamini, Bandyk et al. 1989, Atanassova, Meindl et al. 2001). 
Several bacterial quantification techniques are discussed in the literature 
(Alarcon, Vicedo et al. 2006, Stepanović, Vuković et al. 2007), however a generic 
method, used by the majority is not readily recognised.  This chapter focuses on 
optimising biofilm growing conditions.  
Firstly, we looked at growth media. Historically a multitude of different growth 
medias have been used for staphylococcal culture including; TSB, BHI, Nutrient 
Broth (NB) and Meat infusion broth (MIB) to name a few (May, Houghton et al. 
1964, Christensen, Simpson et al. 1982, Safdar, Narans et al. 2003). Media 
composition is largely determined by the nature of the experiment and the 
properties and growth characteristics of the bacterial strains (Monod 1949). 
Whilst media such as BHI and TSB provide a nutritious environment for bacterial 
growth, the ability to incorporate future mesenchymal cell co-culture studies 
would be limited (Mandel and Tas 2010, Tsimbouri, McMurray et al. 2012, 
Tsimbouri, Gadegaard et al. 2014). Osteointegration is essential for long-term 
survival of TJR. The culture medium used in this study therefore had to be 
optimal for culture of mesenchymal stem cells as well as bacteria. DMEM + 
supplements (FBS, L-glutamine, Sodium Pyruvate and non-essential amino acids) 
has been used extensively in cell culture laboratories (Webber, Harris et al. 
1985, Palmer, Schwartz et al. 2001, Dalby, Cates et al. 2004), therefore we used 
this media in the novel setting of bacterial culture to represent the clinical 
situation. Our results show that throughout all bacterial strains, DMEM + 
supplements caused significantly higher bacterial growth when compared to 10%, 
25%, 50% and 75% FCS media (2.4.1). Additionally, in the majority of strains, 
DMEM + supplements was significantly better at supporting bacterial growth than 
DMEM alone. While more classical media such as TSB also promoted bacterial 
growth, it was not significantly more than DMEM + supplements. While DMEM + 
supplements did not produce the highest bacterial concentrations (BHI was 
significantly better for bacterial growth and culture when compared to all other 
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culture media), it did still promote bacterial growth and had the advantage of 
being a more clinically representative. It was therefore used as the optimal 
culture media for all subsequent bacterial biofilm experiments in this study.  
Of the bacterial strains used, all were successfully cultured to produce standard 
curves as described in section 2.3.2.3. All R2 values fell within our inclusion 
criteria (R2 >0.97), and therefore provided a good linear association between Ct 
values and bacterial concentrations.  As mentioned previously, all strains showed 
similar growth kinetics in relation to media selection. At this stage, due to time 
restraints, focus was applied to the Newman’s strain. Initially isolated in 1952 
from a human infection (thought to be osteomyelitis), this strain has been used 
extensively in animal models. In our study it provided the most reproducible 
results, with 100% of all overnight cultures being successful. It showed similar 
growth kinetics to the other 2 S. aureus strains, and was therefore felt to be 
suitable to represent the S. aureus family. 
The majority of current bacterial quantification methods are based on the 
microtitre plate method described above. These can broadly be divided into 
biofilm biomass assays, viability assays and matrix quantification assays. Whilst 
all useful, each have drawbacks. Biomass assays are based on quantification of 
matrix as well as cells, the most common of which is crystal violet (CV). This 
method, first described by Christensen et al, 1985 (Christensen, Simpson et al. 
1985), has been modified over the years, but still stains all cells and matrix. In 
addition it is usually only accurate after a prolonged period of bacterial growth 
(12-24h) and therefore has limited use in the identification of the early stages of 
biofilm development (Stepanović, Vuković et al. 2000). Viability assays count 
viable cells, but often rely on fluorogenic dyes, such as Syto9, to stain viable 
DNA (Boulos, Prevost et al. 1999). This method is used extensively in bacterial 
and yeast biofilm biomass quantification (Honraet, Goetghebeur et al. 2005, 
Honraet and Nelis 2006). Thus, given its widespread use, this method was 
trialled as a useable method. Unfortunately however, our experiments were 
restricted as our nanotopographies were imprinted on semi-transparent wells, 
which resulted in over-spill of fluorescence into neighbouring wells when 
measuring OD, causing inaccurate readings. Matrix quantification assays clearly 
measure only biofilm matrix and are therefore of limited use looking at bacterial 
adhesion, a stage that occurs before matrix production. Given the issues 
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described, qPCR was employed as a method of quantifying bacteria. Used 
extensively in dental (Williams, Trope et al. 2006) and medical (Larsen, 
Vogensen et al. 2010) fields, qPCR provides a real time quantification of 
bacterial DNA. Our analysis of the bacterial concentration following different 
bacterial incubation periods showed that after 90 min, bacterial concentrations 
were significantly higher when compared to both 30 and 60 min incubations in 
clinical and Newman’s strains. When correlated with our bacterial growth curve, 
this suggests that at 90 min, the bacteria are in the exponential phase of growth 
and therefore adhesion/aggregation has already occurred. In contrast, no 
significant difference was noted between 30 and 60 min incubations, suggesting 
a pre-exponential growth phase environment representing the 
adhesion/aggregation phase of bacterial growth. Thus the optimal incubation 
time for bacteria adhesion was found to be 60 min. 
The final area we optimised was the DNA extraction protocol used for qPCR. As 
per our methods (2.3.2), we focused on optimising the lysozyme incubation 
period. Our aim was to remove all adherent bacteria, and therefore achieve 
maximum DNA yields from each extraction and subsequent qPCR. Effective lysis 
is recognised as a key factor in the purification and extraction of bacterial DNA  
(Schutzbank and Kahmann). Lysozymes act primarily on the cell wall, causing 
enzymatic cell lysis by splitting polysaccharide (peptidoglycan) chains (Salazar 
and Asenjo 2007). Their action is therefore highly dependent on the cell wall 
constituents. Gram positive bacterial cell walls are composed of multiple layers 
of peptidoglycans which compromise around 90% of the cell structure (Sigma-
Aldrich 2015). Lysozyme is therefore an extremely efficient agent for lysing gram 
positive bacteria. Of note, the specific lysozyme we used was ready-lyse 
lysozyme, which works at lower concentrations and over a larger pH range 
(Epicentre 2014). We found that significantly higher quantities of DNA were 
extracted at 120 min when compared to 60, 180 and 240 min. At 60 min 
incubation, it is likely that the lysozyme had not lysed all the cell walls resulting 
in a lower DNA concentration following qPCR. The lysozyme is clearly working at 
this stage, as DNA was extracted and quantified; therefore it seems that 
experimental conditions (as recommended by Epicentre®, Illumina®) were 
adequate. The cause of reduced DNA concentration following extractions at 180 
and 240 min is less clear. It may be that following bacterial cell lysis, if left for a 
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prolonged time (i.e. >120 min), DNA degradation occurs resulting in a reduced 
DNA concentration following extraction. DNA is certainly known to degrade 
following cell apoptosis (Wyllie 1980, Jacobson, Weil et al. 1997), therefore is 
seems likely this occurs after forced bacterial cell lysis with lysozyme. The 
optimal lysozyme incubation time of 120min was therefore used for all 
subsequent experiments involving DNA extraction and qPCR. These optimisation 
experiments are summarised in the flow diagram below (Figure 2-5). 
 
Figure 2-5 Optimisation experiment optimisation flow diagram. 
In conclusion, this initial pilot study produced optimal, reproducible and 
quantifiable bacterial biofilms. Bacterial incubation in DMEM + supplement 
media for 60min was felt to represent the adhesion phase of biofilm 
development which is the focus of this study. Under these conditions, a lysozyme 
incubation period of 120min produced the highest DNA qPCR yields, and was thus 
felt to be optimal. 
 
   
Chapter 3  
 
Biofilms and Nanotopographies 
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3.1 Introduction 
Adhesion is recognised as the first stage of bacterial biofilm development (Sauer, 
Camper et al. 2002, Hall-Stoodley, Costerton et al. 2004, Jahoda 2009). Whilst 
dependent on cell-surface interactions as described previously, alterations to 
the surface topography at a nanoscale has also been shown to have major 
effects on cell behaviour (McMurray, Gadegaard et al. 2011), bacterial adhesion 
(Xu and Siedlecki 2012) and ultimately long term implant survival (Sjöström, 
Brydone et al. 2013). Submicron surface textures on polyurethane has been 
shown to significantly reduce bacterial adhesion when looking at S. aureus and 
S. epidermidis, with a subsequent reduction in biofilm formation (Xu and 
Siedlecki 2012). Further studies have suggested that by changing the surface 
roughness of titanium, bacterial biofilm development can be altered. Ivanova et 
al 2009 found that as surface roughness is increased, bacterial attachment of S. 
aureus decreases (Ivanova, Truong et al. 2009). These results are however far 
from universal. Whilst some studies have shown a bacterial adhesion preference 
to trenches, known as contact guidance (Díaz, Schilardi et al. 2008), others have 
shown no preference to surface topography and disregarded surface roughness as 
factor in adhesion (Bos, van der Mei et al. 1999). The results of these 
contradictory studies are almost certainly due to differences in manufacturing 
methods and specific nanopatterns used. Studies looking at the effects of nano-
roughness are based on the degree of roughness associated with a particular 
surface at the nanometre level (Ivanova, Truong et al. 2009). This is not a 
regulated nanopattern in the form of nanopits or nanowires, rather a roughened 
surface that is given an average ‘roughness’ value. To some extent therefore, 
the exact structure of the surface is unknown. In comparison, the research by 
Diaz et al 2003 provided continuous nano-channels in which bacteria 
preferentially grew (Díaz, Schilardi et al. 2008). It should be noted however that 
these channels were embedded, therefore could it be that the bacteria are 
simply settling into these channels and are unable to ‘escape’ and interact with 
other bacterial channels. There are clearly challenges and variations associated 
with fabricating surfaces at the nanoscale. Our study initially looked at 
nanopatterned polystyrene surfaces and subsequently focused on titanium 
nanosurfaces, each of which will now be introduced. 
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Synthetic plastics have been used in various nanotopography studies, due to 
their relatively low cost and ease of production (Sjöström, Dalby et al. 2009, 
Biggs, Richards et al. 2010, Sjöström, Brydone et al. 2013). Whilst not all plastics 
are commonly used directly in operative orthopaedics, their importance should 
not be underestimated. Chung et al found that catheter associated infections 
can be reduced by altering the nanotopography on the silicone elastomer 
Silastic® (Chung, Schumacher et al. 2007), whilst Xu et al found similar results on 
polyurethane (Xu and Siedlecki 2012). The former study created a 
nanotopography based on shark skin (aptly named Sharklet AFTM) that consisted 
of rectangular ribs of varying lengths (4-16µm) with regular 2µm spacing. The 
protruding features of this topographical surface appeared to provide a physical 
barrier that prevented the expansion of small clusters of bacteria present within 
the recesses into microcolonies (Chung, Schumacher et al. 2007). Although 
prevention of bacterial adhesion is the focus of this study, the importance of an 
orthopaedic implant to osseointegrate must also be recognised. Surface 
topography is known to have effects on cell behaviour (McMurray, Gadegaard et 
al. 2011) as well as bacterial adhesion (Xu and Siedlecki 2012). Dalby et al 
demonstrated that highly ordered nanotopographies (supplied by the Gadegaard 
group, University of Glasgow) produce low cellular adhesion and osteoblastic 
differentiation whilst cells on random nanotopographies exhibited a more 
osteoblastic morphology (Dalby, Gadegaard et al. 2007, Hart, Gadegaard et al. 
2007). This suggests that the use of disorder may be an effective strategy in 
promoting influence over at least mesenchymal stem cells (MSCs) for 
regenerative medicine and tissue engineering. Collaboration with both the Dalby 
and Gadegaard groups has allowed the use of these novel nanotopographies for 
our bacterial adhesion studies.  
Our study initially focussed on polystyrene nanosurfaces that have previously 
shown osseointegrative properties in MSC research (Dalby, Gadegaard et al. 
2007, Hart, Gadegaard et al. 2007), with the hypothesis that bacterial adhesion 
may also be affected. Subsequently we also looked at the more clinically 
relevant nanopatterned materials, Ti. 
Titanium is the most commonly used metal in modern orthopaedic arthroplasty 
surgery (Ramachandran 2006). This is primarily due to its relative low Young’s 
modulus of elasticity (110GPa) when compared with other metals used in 
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orthopaedics such as cobalt-chrome (230GPa) and stainless steel (190GPa) (Katti 
2004). In addition, titanium alloys also show good wear characteristics, excellent 
biocompatibility and fatigue resistance, the only downside being the relative 
expense (Learmonth, Young et al.), costing up to five times as much per 
kilogram than stainless steel. Given titanium’s widespread use in orthopaedic 
implant production, inclusion of nanopatterned titanium in our study was a novel 
and key feature. The titanium nanosurfaces were produced and supplied by our 
collaborators at the School of Oral and Dental Sciences, University of Bristol, 
Bristol, UK.  
3.2 Chapter Aims 
It was the hypothesis of this study that surface nanotopography affects the 
ability of staphylococci species to adhere. This chapter aims to investigate 
whether different materials and nanosurfaces, focussing on nanopits in 
polystyrene and nanowires, nanocauseways and nanograss in titanium, affect 
bacterial adhesion.  
Work from this chapter has been published in: 
Hansom D et al THE EFFECTS OF NANOPATTERN SURFACE TECHNOLOGY ON 
ORTHOPAEDIC JOINT REPLACEMENT INFECTION. Bone & Joint Journal 
Orthopaedic Proceedings Supplement, 2015. 97-B(SUPP 3): p. 2. 
Work from this chapter has been presented at the following conferences: 
Hansom D, Tsimbouri M, Ramage G, Burgess K, Dalby M, Meek D and Clarke J. 
‘Nano-topographical modulation of cells and bacteria for next generation 
orthopaedic implants.’ Centre of Cell Engineering – Glasgow Orthopaedic 
Research Initiative, December 2014. 
Hansom D, Burgess K, Meek D, Clarke J, Ramage G. ‘The effects of nanopattern 
surface technology on orthopaedic joint replacement.’ Glasgow Meeting of 
Orthopaedic research, March 2015. 
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Hansom D, Burgess K, Meek D, Clarke J, Ramage G ‘Nano-topographical 
modulation of cells and bacteria for next generation orthopaedic implants.’ El-
Minia University Hospital Scientific Day, Egypt, February 2015. 
Hansom D, Burgess K, Gadengaard N, Millar N, Clarke J & Ramage G. ‘The 
effects of nanopattern surface technology on orthopaedic joint replacement.’ 
European Federation of National Associations of Orthopaedics and Traumatology, 
June 2016. 
Hansom D, Burgess K, Gadengaard N, Millar N, Clarke J & Ramage G. ‘The 
effects of nanopattern surface technology on orthopaedic joint replacement.’ 
British Orthopaedic Research Society, September 2016. 
3.3 Materials and Methods 
S. aureus Newman strain was used for these experiments. Bacteria was 
collected, cultured and standardised under optimal growth conditions as per 
Chapter 2.  
3.3.1 Polystyrene nanosurfaces 
3.3.1.1 Production 
Manufacture of polystyrene nanosurfaces was carried out by our collaborators at 
the Biomedical Interfaces at Glasgow Group, School of Engineering, University of 
Glasgow. 24 nanopattern surfaces were imprinted onto a polystyrene microscope 
slide. Each nanosurface was a circle with the same diameter as that found on a 
polystyrene 96-well, flat-bottomed microtitre plate (Corning incorporated, NY, 
USA). A purpose build well-type structure was then designed, and this was 
welded to the above-mentioned microscope slide containing different 
nanopatterns. These two sections were designed and made by our collaborators 
(Department of Electronics and Electrical Engineering, University of Glasgow, 
Glasgow, G12 8QQ, U.K), however, welding was carried out by the author. The 
microscope slide and well structure was welded together using an ultrasound 
welder (Standard 3000, Rinco Ultrasonics, Switzerland). Before welding, the 
correct orientation of microscope slide to well structure was checked, ensuring 
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each nanopattern was centred at the bottom of each well. The well layout is 
shown in Figure 3-1.  
 
Figure 3-1 24 well polystyrene nanosurface layout 
Diagrammatic representation of a 24-well nanosurface polystyrene plate where 
DSQ = disordered square, HEX = Hexagonal, SQ = Square, NEAR = near square. 
The number following each arrangement type represents the offset in nm from 
the true centre position. 
Due to time constraints, only selections of the above nanopatterns were 
analysed. These were Control, DSQ10, DSQ50, DSQ100, DSQ150, NEAR50, HEX 
and SQ. It was felt that this gave a good representation of the different 
nanosurfaces available. If required at a later date, the remaining surfaces could 
be studied. 
3.3.1.2 24-well plate sterilisation 
Before bacterial work could commence all polystyrene 24-well plates were 
sterilised. Each well was filled with 200µL of 70% ethanol for 15min. Following 
this period, the ethanol was removed and the wells thoroughly washed out with 
PBS twice. The plates were then placed under a hood (Microflow biological 
safety cabinet, Astec, Hampshire, UK) until air-dried. Each plate was then sealed 
with Parafilm® to maintain sterility until required. 
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3.3.1.3 Bacterial growth quantification 
S. aureus Newman strain was cultured, grown overnight and standardised as 
described in (2.3.1). Following standardisation in DMEM + supplement media, 
150µL of each sample was added to defined wells in a pre-sterilised, polystyrene 
24-well plate as previously described (3.3.1.2). The plate was incubated at 37oC 
on a shaking platform for 1 hour. Following removal, supernatant liquid was 
removed and each well was gently washed with PBS to remove any non-adherent 
bacteria. At this stage, 150µL of TE buffer was added to each well in addition to 
1µL of lysozyme, as per the DNA extraction protocol described (2.3.2). Following 
lysozyme incubation for 2 hours, each sample was transferred to a 1.5mL 
microfuge tube and DNA extraction and subsequent bacterial quantification 
using DNA qPCR was carried out (2.3.2.3). Previously obtained standard curves 
allowed bacterial concentrations to be calculated based on the Ct values 
obtained. All experiments were carried out in triplicate and repeated 3 times. 
3.3.1.4 Imaging of bacteria 
S. aureus Newman strain was cultured, grown overnight and standardised as 
described in (2.3.1). Following standardisation in DMEM + supplement media, 
150µL of each sample was added to defined wells in a pre-sterilised, polystyrene 
24-well plate as previously described (3.3.1.2). The plate was incubated at 37oC 
on a shaking platform for 1 hour. Following removal, supernatant liquid was 
removed and each well was gently washed with PBS to remove any non-adherent 
bacteria. Samples were then allowed to air dry under a hood (Microflow 
biological safety cabinet, Astec, Hampshire, UK) and subsequently heat fixed. 
Each plate was then sealed with Parafilm® to maintain sterility until required. 
Polystyrene nanosurfaces were imaged using the EVOS® FL Auto cell imaging 
system (Life Technologies, Paisley, UK). A purpose build 24-well plate holder was 
designed to be used in conjunction with the above microscope. This allowed 10 
randomly selected images to be taken of each polystyrene nanosurface. These 
images were then analysed using Cell Profiler® software (Carpenter, Jones et al. 
2006), which provided a percentage bacterial coverage value for each surface. 
Percentage coverage values were then compared between surfaces. This 
experiment was carried out in triplicate. 
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3.3.1.5 Statistical analysis 
Graph production and statistical analysis were performed using GraphPad prism 
software (version 4; La Jolla, CA, USA). One-way analysis of variance (ANOVA) 
was used to investigate significant differences between independent pattern 
groups. If ANOVA revealed a statistical significance, a Dunnett’s multiple 
comparison test was performed to determine statistical significance between 
groups. Statistical significance was achieved if P<0.05.  
3.3.2 Titanium nanowires, nanocauseways and nanograss 
3.3.2.1 Production 
Manufactured titanium and control surfaces were provided by our collaborators 
(School of Oral and Dental Sciences, University of Bristol, Bristol, UK). Ti 
nanowire (NW) production method was not the focus of this study, however in 
brief; each Ti surface was prepared from a 0.9 mm thick ASTM grade 1 Ti sheet 
(Ti metals Ltd, UK). The samples were polished to a mirror image and 
ultrasonically cleaned in water and ethanol. These polished samples were used 
as our control surface. For the nanowire formation, the Ti disks were immersed 
in 1M sodium hydroxide (NaOH) in a Polytetrafluoroethylene (PTFE) lined steel 
vessel (Acid Digestion vessel 4748, Parr Instrument Company, USA), which was 
placed in an oven at a temperature of 240°C. The vessel was removed from the 
oven and allowed to cool to room temperature after 2, 2.5 or 3hr’s. Each NW 
surface was rinsed in water and ethanol, sequentially. To convert the NaTiO2 to 
TiO2 the samples were immersed in 0.6M Hydrogen Chloride (HCl) for 1 h, rinsed 
in water and ethanol, and finally heat treated at 600°C for 2 h. Examples of the 
Ti NW structures are shown in Figure 3-2. Samples were stored in sterile 
containers until required. 
Manufactured Ti nanocauseway (NC), nanograss (NG) and control surfaces were 
also provided by our collaborators (School of Oral and Dental Sciences, 
University of Bristol, Bristol, UK). Their production differed slightly from the NW 
surfaces, which will be briefly highlighted. These surfaces were made from 
grade 5, Ti-6Al-4V (Ti64) (Ti-Tek (UK) Ltd) with a thickness of 1 mm. Ti64 
squares (10mm2) were cut, polished and ultrasonically washed in distilled water, 
and finally air dried. The squares were then placed inside a ceramic tube  
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Figure 3-2 Imaging of nanowire structures 
SEM images of 2 Hr treated titanium NW structure – x10000 magnification (A) and 
x30000 magnification (B). 2.5 Hr treated titanium NW structure - x10000 
magnification (C) and x30000 magnification (D).  3 Hr treated titanium NW 
structure - x10000 magnification (E) and x30000 magnification (F) (Images 
provided by (Sjöström, Brydone et al. 2013)).  
furnace, which was flushed with argon (Ar) at a flow rate of either 50 (NC) or 
200 (NG) standard cubic centimetres per min (sccm) for 30 min. The tube was 
then heated to 850°C at a rate of 15°C/min. After reaching final temperature, 
acetone vapour was introduced into the tube by passing the Ar through a bottle 
containing acetone. The temperature was kept at 850°C with acetone vapour for 
30 min, after which the tube was cooled to room temperature. The squares were 
then annealed at 600°C for 30 min in air to remove the carbon from the 
surfaces. Examples of the Ti NC and NG structures are shown in Figure 3-3 . 
Samples were stored in sterile containers until required. 
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Figure 3-3 Imaging of NG and NC structures 
SEM images of NC structure – x10000 magnification (A) and x20000 magnification 
(B). NG structure - x10000 magnification (C) and x20000 magnification (D) 
(Images provided by (Sjöström, Dalby et al. 2009)).   
3.3.2.2 Sterilisation 
Before bacterial work could commence all titanium samples were sterilised in a 
24-well plate (Corning incorporated, NY, USA). Each well (containing 1 titanium 
sample) was filled with 500µL of 70% ethanol for 15mins. Following this period, 
the ethanol was removed and the samples were thoroughly washed with PBS 
twice. Samples were then placed under a hood (Microflow biological safety 
cabinet, Astec, Hampshire, UK) until air dried and subsequently sealed in a 
sterile container with Parafilm® until required. 
3.3.2.3 Bacterial growth quantification 
S. aureus Newman strain was cultured, grown overnight and standardised as 
described in (2.3.1). Following standardisation in DMEM + supplement media, 
500µL of each sample was added to defined wells in a pre-sterilised, standard 
polystyrene 24-well plate containing titanium surfaces. The plate was incubated 
at 37oC on a shaking platform for 1 hour. Following removal, supernatant liquid 
was removed and each sample was gently washed with PBS to remove any non-
adherent bacteria. Each sample was then carefully removed and added to a 
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bijous containing 500µL of PBS and ultrasonnicated for 10 minutes at room 
temperature (Ultrasonic Heated bath, Fisherbrand®, Leicestershire, UK). It 
should be noted that it is impossible to remove all bacteria from the surfaces, 
however this method was the most successful and constant across all samples. 
Each sample was removed and the remaining liquid was transferred to a 1.5mL 
microfuge tube and centrifuged for 10 min at 5000rpm. All supernatant liquid 
was then discarded and 150µL of TE buffer was added to each tube in addition to 
1µL of lysozyme, as per the DNA extraction protocol described (2.3.2.1) 
Following lysozyme incubation for 2 hours, DNA extraction and subsequent 
bacterial quantification using DNA qPCR was carried out (2.3.2.3). Previously 
obtained standard curves allowed bacterial concentrations to be calculated 
based on the Ct values obtained. All experiments were carried out in triplicate 
and repeated 3 times. 
3.3.2.4 Imaging of bacteria 
S. aureus Newman strain was cultured, grown overnight and standardised as 
described in (2.3.1). Following standardisation in DMEM + supplement media, 
500µL of each sample was added to defined wells in a pre-sterilised, standard 
polystyrene 24-well plate containing sterile Ti nanosurfaces. The plate was 
incubated at 37oC on a shaking platform for 1 hour. On removal, all supernatant 
was discarded and each sample was gently washed with PBS twice. SYTO®9 green 
fluorescent nucleic acid stain (Life Technologies, Paisley, UK) was used at a 
dilution of 2µL/ml in deionised water. 150µL of the nucleic acid stain was added 
to each sample and incubated in the dark at 370C for 20 minutes. Residual stain 
was then removed, and each sample was mounted on a microscope slide with a 
coverslip and imaged (Motic BA 400 microscope [Wetzlar, Germany] with 
CoolLED fluorescence excitation system [Andover, UK]) at 100x magnification. 
Image capture and analysis was carried out using Cell B imaging software 
(Olympus Soft Imaging solutions, version 2.5). These images were then further 
analysed using Cell Profiler® software (Carpenter, Jones et al. 2006), which 
provided a percentage bacterial coverage value for each surface. Percentage 
coverage values were then compared between surfaces. This experiment was 
carried out in triplicate, with 4 randomly selected images from each sample 
being used, giving a total of 12 images per surface. 
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3.3.2.5 Scanning electron microscopy (SEM) 
S. aureus Newman strain was cultured, grown overnight and standardised as 
described in (2.3.1). Following standardisation in DMEM + supplement media, 
500µL of each sample was added to defined wells in a pre-sterilised, standard 
polystyrene 24-well plate containing different titanium nanosurfaces. The plate 
was incubated at 37oC on a shaking platform for 1 hour. Following incubation, 
samples were carefully washed with PBS and then fixed (2% para-formaldehyde, 
2% gluteraldehyde, 0.15M sodium cacodylate and 0.15% w/v alcian blue (pH 7.4) 
for 18 hrs. The fixative was then removed and samples were washed with 0.15M 
sodium cacodylate buffer three times and then stored in 0.15M sodium 
cacodylate buffer at 4oC until processing. Sample processing was carried out as 
described by Erlandsen et al, 2004 (Erlandsen, Kristich et al. 2004), allowing 
image acquisition using SEM. Randomly selected images were taken at x1000, 
x5000 and x10,000 magnifications for each surface.  
3.3.2.6 Statistics 
Graph production and statistical analysis were performed using GraphPad prism 
software (version 4; La Jolla, CA, USA). One-way analysis of variance (ANOVA) 
was used to investigate significant differences between independent pattern 
groups. If ANOVA revealed a statistical significance, a Dunnett’s multiple 
comparison or Tukey’s test was performed to determine statistical significance 
between groups, depending on individual experiments. If two pattern groups 
were compared, an unpaired student’s T-test was employed. Statistical 
significance was achieved if P<0.05.  
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3.4 Results 
3.4.1 Polystyrene nanosurfaces 
3.4.1.1 Bacterial Concentrations 
S. aureus Newman strain was cultured and grown under optimal conditions on 
different polystyrene nanopatterned surfaces in custom made 24-well plates. 
The results show a reduced bacterial concentration on the HEX and SQ 
nanosurfaces when compared to the control surface and other nanosurfaces 
(Figure 3-4). This trend was noted in all replicates; however, did not reach 
statistical significance. The highest bacterial concentrations were noted on the 
NEAR and DSQ 50 patterns when compared to control and remaining 
nanosurfaces. These observations were again, noted across all replicates but not 
found to be significant. 
 
Figure 3-4 Average bacterial concentration on different polystyrene 
nanopatterned surfaces. 
S. aureus Newman strain was standardised in DMEM + supplement media and 
grown on various nanopatterned polystyrene surfaces for a period 1 hour. 
Bacterial concentrations appeared to be lower on HEX and SQ patterns, when 
compared to Control, DSQ10, 50, 100, 150 and NEAR 50. This trend was not 
significant. 
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3.4.1.2 Imaging 
Following culture and growth of S. aureus Newman strain on different 
polystyrene nanopit surfaces, each surface was imaged as described previously 
(3.3.1.4). Data analysis by Cell Profiler® software allowed the percentage 
bacterial coverage for each nanosurface to be calculated. It was assumed that 
the greater the percentage bacterial coverage; the higher bacterial adhesion to 
that particular surface. As illustrated below (Figure 3-5), percentage bacterial 
coverage is significantly lower on the HEX (P=0.05) and SQ (P=0.01) patterns 
when compared to the control surface, with an average coverage of 2% and 0.9% 
respectively. The highest bacterial percentage coverage was noted on Control, 
DSQ100 and NEAR50 with average percentage coverage of 4.2%, 3.7% and 3.6% 
respectively.  
 
Figure 3-5 Average bacterial percentage coverage on different polystyrene 
nanopatterned surfaces. 
S. aureus Newman strain was standardised in DMEM + supplement media and 
grown on various nanopatterned polystyrene surfaces for a period 1 hour. 
Bacterial percentage coverage was significantly lower on HEX and SQ patterns, 
when compared to Control (#P=0.05, ##P=0.01 respectively). No significant 
difference was noted between all other surfaces.  
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3.4.2 Titanium nanowires 
3.4.2.1 Bacterial concentrations 
S. aureus Newman strain was cultured overnight and standardised in optimal 
media as previously described (2.3.1). S. aureus Newman strain was grown under 
optimal conditions on different Ti control (polished) and NW discs in 24-well 
plates. We found significantly higher bacterial concentrations on the 2.5Hr 
(P<0.05) and 3Hr (P<0.01) NW materials when compared to the control, polished 
Ti discs. Whilst the bacterial concentration was higher on the 2Hr discs, when 
compared to the polished control, this increase was not found to be significant. 
In addition, bacterial concentration was noted to increase incrementally as the 
duration of Ti disc treatment increased (i.e. surface nanoroughness). Although 
noted across all samples, no significant difference was noted between NW 
surface (Figure 3-6). 
 
 
Figure 3-6 Average bacterial concentration on Ti NW surfaces 
S. aureus Newman strain was standardised in DMEM + supplement media and 
grown on various NW Ti discs for a period 1 hour. Bacterial concentrations were 
significantly higher on the 2.5Hr (#P<0.05) and 3Hr (##P<0.01) discs when 
compared to the control Polished disc. No significant difference was noted 
between the 2Hr disc and the Polished, 2.5Hr and 3Hr discs.  
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3.4.2.2 Imaging 
Following culture and growth of S. aureus Newman strain on different control 
(polished) and NW discs in 24-well plates, samples were stained and imaged as 
described previously (3.3.2.4). This provided a visual representation of the 
bacterial concentrations to support DNA extraction and qPCR data. As can be 
seen (Figure 3-7), the amount of nucleic acid stain appears least on the polished 
Ti control discs, with increasing fluorescence on the 2Hr, 2.5Hr and 3Hr NW Ti 
discs respectively. 
 
Figure 3-7 Fluorescent bacterial staining on different Ti NW surfaces 
SA Newman strain was standardised in DMEM + supplement media and grown on 
various NW Ti discs for a period 1 hour. Following staining with SYTO®9 green 
fluorescent nucleic acid stain slides were imaged. 4 randomly selected images 
were taken from each slide (providing 12 images of each surface), the most 
representative of which are shown above. The least nucleic acid appears on the 
polished, control Ti disc, with increasing fluorescence on 2Hr, 2.5Hr and 3Hr Ti 
NW surfaces respectively.  
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These images were subsequently analysed using Cell Profiler® software, thus 
allowing the percentage bacterial coverage for each NW surface to be 
calculated. It was assumed that the greater the percentage bacterial coverage; 
the higher bacterial adhesion to that particular surface. As illustrated below 
(Figure 3-8), percentage bacterial coverage was significantly higher (P<0.001) on 
the 2Hr, 2.5Hr and 3Hr NW surfaces when compared to the control, polished 
surface (average percentage coverage values :10.7%, 10.9% and 12.8% 
respectively in comparison to 2.9% on the control surface). This supports the 
bacterial concentration data obtained from DNA extraction and qPCR (3.4.2.1). 
 
Figure 3-8 Average bacterial percentage coverage on different Ti NW pattern 
surfaces 
S. aureus Newman strain was standardised in DMEM + supplement media and 
grown on various nanowire pattern Ti surfaces for a period 1 hour. Bacterial 
percentage coverage was significantly higher on 2Hr, 2.5Hr and 3Hr surfaces 
when compared to the polished control surface (#P<0.001). No significant 
difference was noted between nanowire patterns.  
3.4.2.3 SEM imaging 
In addition to the above, different nanowire surfaces were imaged using SEM to 
give a visual representation of bacterial/nanowire interactions (Figure 3-9 and 
Figure 3-10). These images appear to demonstrate increased bacterial 
concentrations on the 2Hr, 2.5Hr and 3Hr NW surfaces when compared to the 
control surface respectively. Increased bacterial ‘clustering’ is also evident on 
 Ch.3 Biofilms and Nanotopographies 
 65 
the 2.5Hr and 3Hr Ti NW surfaces when compared to the control surface. 
 
Figure 3-9 SEM images of Control and 2Hr Ti NW 
S. aureus Newman strain was standardised in DMEM + supplement media and 
grown on control and 2Hr NW Ti surfaces for a period 1 hour. Following fixation 
and processing all slides were imaged using SEM. A=Control x1000 magnification, 
B=Control x5000 magnification, C=Control x10000 magnification, D=2hr x1000 
magnification, E=2Hr x5000 magnification, F=2Hr x 10000 magnification. 
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Figure 3-10 SEM images of 2.5Hr and 3Hr Ti NW 
S. aureus Newman strain was standardised in DMEM + supplement media and 
grown on 2.5Hr and 3Hr NW Ti surfaces for a period 1 hour. Following fixation 
and processing all slides were imaged using SEM. A=2.5Hr x1000 mag, B=2.5Hr 
x5000 magnification, C=2.5Hr x10000 magnification, D=3hr x1000 magnification, 
E=3Hr x5000 magnification, F=3Hr x 10000 magnification. 
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3.4.3 Titanium NC and NG surfaces 
3.4.3.1 Bacterial concentration 
S. aureus Newman strain was cultured overnight and standardised in optimal 
media as previously described (2.3.1). S. aureus Newman strain was grown under 
optimal conditions on Ti control, NC and NG surfaces in 24-well plates. We found 
significantly lower bacterial concentrations on the NC surface when compared to 
the control Ti surface (P<0.05). In contrast similar bacterial concentrations were 
noted between the control and NG groups with no statistical difference (Figure 
3-11).  
 
 
Figure 3-11 Average bacterial concentration on Ti NC, NG and control 
surfaces 
S. aureus Newman strain was standardised in DMEM + supplement media and 
grown on NC, NG and control Ti surfaces for a period 1 hour. Bacterial 
concentrations were significantly lower on the NC Ti surface (#P<0.05). No 
significant difference was noted between the NG and control Ti surfaces.   
3.4.3.2 Imaging 
Following culture and growth of S. aureus Newman strain on control, NC and NG 
surfaces in 24-well plates, samples were stained and imaged as described 
previously (3.3.2.4). This provided a visual representation and comparison of the 
bacterial coverage on NC, NG and control surfaces. As can be seen (Figure 3-12), 
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the amount of nucleic acid stain appears least on the NC surfaces with increasing 
fluorescence on the NG and polished (control) surfaces.  
 
Figure 3-12 Fluorescent bacterial staining on Polished, NG and NC surfaces 
SA Newman strain was standardised in DMEM + supplement media and grown on 
polished (control), NG and NC Ti surfaces for a period 1 hour. Following staining 
with SYTO®9 green fluorescent nucleic acid stain slides were imaged. 4 randomly 
selected images were taken from each slide (providing 12 images of each 
surface), the most representative of which are shown above. The least nucleic 
acid appears on the NC surface when compared to the NG and polished control 
surfaces.  
These images were subsequently analysed using Cell Profiler® software, thus 
allowing the percentage bacterial coverage for each nanowire surface to be 
calculated. Again it was assumed that the greater the percentage bacterial 
coverage; the higher bacterial adhesion to that particular surface. As illustrated 
(Figure 3-13), percentage bacterial coverage was significantly lower (P<0.001) 
on the NC surface when compared to both the NG and the control, polished 
surface (average percentage coverage values: 0.19%, 2.21% and 2.29% 
respectively). This supports the bacterial concentration data obtained from DNA 
extraction and qPCR (3.4.3.1).  
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Figure 3-13 Average bacterial percentage coverage on NC, NG and polished Ti 
surfaces. 
S. aureus Newman strain was standardised in DMEM + supplement media and 
grown on NC, NG and polished control Ti surfaces for a period 1 hour. Bacterial 
percentage coverage was significantly lower on the NC surface when compared 
to both the NG and polished control surface (#P<0.001). No significant difference 
was noted between NG and polished control surfaces.  
3.4.3.3 SEM imaging 
In addition to the above, the NC, NG and control surfaces were imaged using SEM 
to give a visual representation of the bacterial/nanosurface interactions (Figure 
3-9 and Figure 3-10). These images demonstrate a similar bacterial coverage on 
both the NG and control Ti surfaces. There is also an increased bacterial 
‘clustering’, particularly on the NG Ti surface under high magnification when 
compared to both the control and NC Ti surfaces. Bacterial coverage and 
‘clustering’ appears reduced on the NC Ti surface across all magnifications when 
compared to the NG and control Ti surfaces.  
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Figure 3-14 SEM images of control and NG Ti surfaces 
S. aureus Newman strain was standardised in DMEM + supplement media and 
grown on control and NG Ti surfaces for a period 1 hour. Following fixation and 
processing all slides were imaged using SEM. A=control x1000 mag, B=control 
x5000 magnification, C=control x10000 magnification, D=NG x1000 
magnification, E=NG x5000 magnification, F=NG x 10000 magnification. 
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Figure 3-15 SEM images of NC Ti surfaces 
S. aureus Newman strain was standardised in DMEM + supplement media and 
grown on NC Ti surfaces for a period 1 hour. Following fixation and processing all 
slides were imaged using SEM. A= NC x1000 mag, B=NC x5000 magnification, 
C=NC x10000 magnification.   
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3.5 Discussion 
Bacteria are known to form biofilms in a multitude of environments, from 
hydrothermic pools (Reysenbach and Cady 2001) and acid mines (Edwards, Bond 
et al. 2000) to infected orthopaedics devices (Xu and Siedlecki 2012). The 
primary stage in bacterial colonisation and subsequent biofilm formation is 
bacterial adhesion (Mack, Nedelmann et al. 1994, Heilmann, Schweitzer et al. 
1996, Sauer, Camper et al. 2002, Hall-Stoodley, Costerton et al. 2004). It has 
been suggested that by altering surface topography, cell behaviour (McMurray, 
Gadegaard et al. 2011), bacterial adhesion (Xu and Siedlecki 2012) and long term 
implant survival can be affected (Sjöström, Brydone et al. 2013). This is 
certainly the case in relation to dental implants, where increased osteoblastic 
cell adhesion, spreading and propagation was demonstrated when grown on 
specific titanium nanopatterns (Pelaez-Vargas, Gallego-Perez et al. 2011). Other 
studies have shown reduced bacterial adhesion on nanopatterned polyurethane, 
and suggests that the accessible contact surface area available for bacterial 
adhesion is important (Xu and Siedlecki 2012). By creating nanopillars, Xu et al 
(2002) reduced the contact surface area by up to 75% when compared to a flat 
control surface (Xu and Siedlecki 2012). Dalby et al found that highly ordered 
nanotopographies (namely the HEX and SQ pattern) produced low cellular 
adhesion and osteoblastic differentiation whilst cells on random 
nanotopographies exhibited a more osteoblastic morphology (Dalby, Gadegaard 
et al. 2007, Hart, Gadegaard et al. 2007). This suggests that the use of disorder 
may be an effective strategy in promoting influence over at least MSCs for 
regenerative medicine and tissue engineering. Similar to the Dalby group using 
MSC’s, our study, using the same nanopit patterns, found reduced bacterial 
adhesion on the SQ and HEX patterns when compared to the control, un-
patterned surface. Although this was not found to be significant when comparing 
bacterial concentrations, a clear trend was noted throughout all technical and 
biological replicates. This was supported by further imaging analysis, showing a 
significantly lower average percentage bacterial coverage on both the SQ and 
HEX patterns when compared to the control surface (P=0.05 and P=0.01 
respectively). Highest bacterial concentrations were found on the DSQ10, 50 and 
NEAR 50 pattern’s, suggesting that bacterial adhesion favours disordered 
nanotopographies. This was again supported by high average percentage 
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coverage values on DSQ100 and NEAR50 surfaces. This has also been observed in 
MSC’s (Dalby, Gadegaard et al. 2007, Hart, Gadegaard et al. 2007), clearly 
showing that nanotopography has huge effects on stem cell differentiation 
(Dalby, McCloy et al. 2006). Mechanisms behind this are still being understood. It 
has been suggested that specific nanotopographical surfaces affect focal 
adhesion via altered protein adsorption to the surface (Oh, Brammer et al. 
2009), and that gene expression in skeletal stem cells changes as a result of 
altered nanotopography (Dalby, Gadegaard et al. 2007, Dalby, Andar et al. 
2008). Could it be that these mechanisms are also occurring in bacteria during 
adhesion? Several studies have also suggested that bacterial micro colony 
formation can be prevented by creating a physical barrier to spread at a 
nanometre level (Chung, Schumacher et al. 2007). It may be that the organised 
SQ and HEX nanopatterns are the optimal nanopit orientations to prevent 
bacteria microcolony formation, keeping the bacteria in small, isolated clusters 
and preventing communication. 
Subsequently, we focused on a more clinically relevant material, Ti. The Ti alloy 
Ti-6A1-4V (Ramachandran 2006) is the most commonly used Ti alloy in 
orthopaedics, due to its reduced elastic modulus, good wear characteristics, 
excellent biocompatibility and fatigue resistance (Learmonth, Young et al.). 
Most research to date has focused on materials other than Ti, using production 
methods previously described (3.3.1.1). Although providing interesting results 
(Chung, Schumacher et al. 2007, Xu and Siedlecki 2012), the translation of these 
nanosurfaces to Ti is critically important, both to prosthetic development and to 
allow verification of findings on other materials (Sjöström, Brydone et al. 2013).  
Our collaborators have designed and developed a technique that allows 
production of highly defined nanopatterns on Ti (3.3.2.1). Unlike previous 
studies that have used Ti nanopillers (Sjöström, Dalby et al. 2009) and controlled 
oxidisation (de Oliveira, Zalzal et al. 2007) to alter the Ti surface, these new 
methods can produce novel surface topographies such as NW, NC and NG (Figure 
3-2 and Figure 3-3). Our research showed a significant increase in bacterial 
concentrations on both the 2.5Hr (P<0.05) and 3Hr (P<0.01) treated Ti NW 
surfaces when compared to the polished Ti control surface after 1 hour bacterial 
incubation (3.4.2.1). This suggests that as nanoroughness increases, so does 
bacterial adhesion. This theory was further supported visually with fluorescent 
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nucleic acid staining that clearly showed increased fluorescence with increasing 
nanoroughness (3.4.2.2). Subsequent image analysis using Cell Profiler® software 
showed average percentage bacterial coverage was significantly higher (P<0.001) 
on the 2Hr, 2.5Hr and 3Hr NW surfaces when compared to the control surface, 
further supporting a bacterial preference for Ti nanoroughened surfaces. Indeed 
unpublished research by our collaborators has suggested that osteogenesis is 
increased on the 2hr treated NW surface, but interestingly is reduced on the 
2.5hr and 3hr NW topographies with significantly lower mean cell numbers when 
compared to a control surfaces (unpublished results, PM Tsimbouri at Dalby 
group, Centre for Cell engineering, University of Glasgow). Whilst the 
explanation behind the osteogenic differences is out with the remit of this 
study, the stepwise increase in bacterial concentrations with nano-roughness 
remains interesting. S. aureus  has been shown to prefer micro-roughened 
titanium, owing to an increased amount of contact guidance when compared to 
smooth surfaces (Ivanova, Truong et al. 2009). The adhesion differences noted 
on our nanowires may therefore be due to similar interactions, albeit at a 
nanoscale. It should also be noted that our nanowire surfaces are not regular or 
uniform. As such, depressed areas within the surface exist (Figure 3-2) which 
may encourage bacterial collection and subsequent adhesion. Whilst visible on 
the 2hr and 2.5hr treated samples, they are clearly more apparent on the 3hr 
surface. This increased roughness or ‘pitting’ may enhance bacterial adhesion 
and subsequent colonisation. Visual analysis of SEM images (Figure 3-9 and Figure 
3-10) certainly appears to show increased bacterial ‘clustering’ as Ti 
nanoroughness increases. This may represent a quicker bacterial adhesion, thus 
allowing increased bacterial communication and perhaps quicker biofilm 
development.  
In addition it has been suggested that surfaces with nanoprotrusions may affect 
bacterial attachment and growth (Ivanova, Truong et al. 2009, Ivanova, Hasan et 
al. 2012, Ivanova, Hasan et al. 2013). The wing nanostructure of a species of 
cicada, Psaltoda claripennis, have been shown to induce cellular death (Ivanova, 
Hasan et al. 2012). This bacteriocidal effect is based primarily on the physical 
surface structure, as significant alteration of the chemistry on the wing (through 
gold covering) failed to prevent cellular death (Ivanova, Hasan et al. 2012). 
Further development of this theory resulted in the production of hexagonal 
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arrays of spherically capped, conical nanopillars that were found to induce the 
same effect on gram-negative organisms such as P. aeruginosa (Ivanova, Hasan 
et al. 2012, Pogodin, Hasan et al. 2013). Subsequent studies have focussed on 
the nanostructure of the dragonfly wing, Diplacodes bipunctata (Ivanova, Hasan 
et al. 2013). Ivanova et al found that fabricated black silica nanopillar 
structures, possessing a disordered arrangement, have a bacteriocidal effect on 
both gram positive and gram negative bacteria, again through physical 
interaction forces that are dependent on the surface of a material (Ivanova, 
Hasan et al. 2013). It is postulated cell death occurs as a result of altered 
surface structure, associated stresses and forced cell deformation. 
Consequently, our research has incorporated similar disordered, hexagonal array 
nanopillars (NC and NG) surfaces onto Ti.  
Our study shows that a disordered NC Ti nanopattern, hexagonal in nature, 
significantly reduced bacterial concentrations following a 1hr incubation period 
when compared to a polished, control surface (P<0.05). The bacterial 
percentage coverage was also noted to be significantly lower on the NC surfaces, 
with over a 10-fold reduction when compared to the control surface. It is 
postulated that this reduction is through similar mechanisms to those described 
by Ivanova et al, and primarily related to altered surface interactions. These NC 
arrangements were generally shorter and wider (200-300nm) than the NG 
surfaces and were noted to have sharp edges and pyramidal shaped tips (Figure 
3-3). Such mechanical characteristics have been shown to cause sufficient 
damage to the bacterial cell membrane, resulting in bacterial cell lysis on silicon 
(Gorth, Puckett et al. 2012). It is therefore postulated that similar interactions 
are occurring on our Ti NC structures. Interestingly however, the NG surface had 
no significant difference on bacterial concentrations or percentage coverage 
when compared to the polished, control surface. These nanostructures have a 
significantly longer length and smaller diameter to the NC surfaces (10-100nm), 
making them less rigid and sharp. It may be therefore, that the NG surfaces are 
simply not strong enough to affect bacterial deformation and subsequent cellular 
death, and instead move to allow bacterial colonisation. Indeed on examination 
of our SEM images, coverage and bacterial clustering appears higher on the NG 
and control surfaces when compared to the NC Ti surfaces at all magnifications 
(Figure 3-14 and Figure 3-15). Clearly the surface structure on a material has 
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significant effects on bacterial adhesion, however from a bone implant 
perspective, finding a structure that is both bacteriocidal and osseoinductive 
may prove difficult. Given that the above surfaces are thought to work via cell 
deformation and altered internal osmotic turgor pressures (Arnoldi, Fritz et al. 
2000, Jiang and Sun 2010), it would seem logical that other cell lineages, such as 
MSC’s will also be affected. As a result, further research in this area is 
recommended. 
In addition to mechano-responsive microbiology, it has been suggested that 
adhesion is mediated by surface proteins (Hussain, Herrmann et al. 1997), 
extracellular proteins (Heilmann, Schweitzer et al. 1996), adhesins (McKenney, 
Hübner et al. 1998) and autolysins (Heilmann and Götz 1998). The exact 
metabolic pathways involved in bacterial adhesion are poorly understood and 
may provide potential targets for anti-microbial treatments. This topic is 
therefore the focus of Chapter 4. 
 
 
 
 
 
 
 
   
Chapter 4  
 
Metabolomic Profiling of Bacterial Adhesion 
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4.1 Introduction 
Metabolomics is defined as ‘the quantitative measurement of the dynamic 
multiparametric metabolic response of living systems to pathophysiological 
stimuli or genetic modification’ (Nicholson, Lindon et al. 1999). Metabolomics is 
the study of a complement of small molecules (known as metabolites) within a 
system, known as the metabolome. The metabolome was first described by 
Oliver et al (1998) whilst studying the yeast genome (Oliver, Winson et al. 1998), 
and resultant metabolomics development is often referred to as metabonomics 
(Nicholson, Lindon et al. 1999) or metabolic profiling (Niwa 1986) by some 
groups. The ability to provide a ‘snap-shot’ of cell metabolism is emerging as a 
useful tool across a multitude of disciplines, ranging from plant physiology to 
human disease, nutrition and drug discovery, but has only become possible as a 
result of recent technological breakthroughs in small molecule separation and 
identification (Wishart 2008).  
The earliest application of a pre-cursor to metabolomics is considered to be the 
use of gas chromatography-mass spectrometry for metabolite profiling of clinical 
urine in the 1970’s (Politzer, Dowty et al. 1976, Jellum 1977, Gates and Sweeley 
1978). Further development of nuclear magnetic resonance (NMR) spectroscopy 
by Nicholson et al in the 1980’s (Bales, Bell et al. 1988) and later mass 
spectrometry (MS), liquid chromatography (LC) and capillary electrophoresis (CE) 
in combination with appropriate software programs has allowed analysis (Dunn, 
Bailey et al. 2005) and rapid development of such analytical techniques. 
Presently, the two main methods used in metabolomics are NMR and MS (Either 
LC or CE) (Goodacre, Vaidyanathan et al. 2004, Dunn, Bailey et al. 2005, Glinski 
and Weckwerth 2006, Dettmer, Aronov et al. 2007). While NMR is recognised to 
require little sample preparation and can offer structural and quantitative 
details about compounds (Giavalisco, Hummel et al. 2008), it has a low 
sensitivity when analysing complex biological samples (Dunn, Bailey et al. 2005, 
Dettmer, Aronov et al. 2007, Eisenreich and Bacher 2007). In comparison, MS-
based methods have better compound separation and are ultimately more 
sensitive. MS methods therefore dominate metabolomic literature (Giavalisco, 
Hummel et al. 2008), and will be the method used in this study. In addition, the 
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information gained from a metabolomics experiment can be further improved by 
the introduction of techniques such as flux analysis (Sauer, Lasko et al. 1999, 
Wiechert 2001, Fischer and Sauer 2003). Essentially this allows the targeting of 
specific compounds that are predicted to be involved in specific metabolomics 
pathways, and relies on the incorporation of labelled isotopes (such as 13C) into 
metabolite pools (Birkemeyer, Luedemann et al. 2005). These compounds can 
subsequently be traced ‘downstream’, highlighting any specific pathways 
demonstrating increased metabolic activity. Another equally important aspect of 
metabolomics is a compiled database containing descriptive and spectral 
information of all constituent chemicals found in different metabolomes (Smith, 
O'Maille et al. 2005, Cotter, Maer et al. 2006, Moco, Bino et al. 2006, Wishart, 
Tzur et al. 2007). The relatively recent production and widespread availability of 
such databases has allowed the detection and characterisation of multiple 
metabolomes in a matter of minutes (Dunn, Bailey et al. 2005, Moco, Bino et al. 
2006, Wishart 2008). 
In general, metabolomics analyses can be classified as either targeted or 
untargeted. Targeted analyses focuses on particular groups of metabolites, 
usually within one or more related pathways of interest (Dudley, Yousef et al. 
2010), allowing identification and quantification of as many metabolites within 
the group as possible (Ramautar, Demirci et al. 2006). This method aims to 
quantify these selected metabolites, usually up to a few hundred compounds and 
requires the ability to differentiate the targeted metabolites from other 
compounds (Lu, Bennett et al. 2008). This method is highly sensitive and robust 
and can be used to isolate potential metabolic signatures for disease. For 
example, targeted metabolomics has recently been used to identify citric acid 
metabolites and a group of essential amino acids as metabolic signatures for 
myocardial ischaemia and diabetes respectively (Sabatine, Liu et al. 2005, Wang, 
Larson et al. 2011). In comparison, untargeted metabolomics aims to detect as 
many groups of metabolites as possible allowing the identification of patterns 
(Monton and Soga 2007) and comparison without bias (Patti, Yanes et al. 2012). 
By using techniques such as LCMS, large numbers of metabolites may be 
identified using relatively small sample volumes (Patti, Yanes et al. 2012). 
Metabolomic software in conjunction with previously described metabolomics 
databases can then be used to identify specific metabolites based on the 
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accurate mass of the compound. This type of metabolomics is useful in 
identification of any altered metabolomic pathways in disease, that may 
represent new drug targets; an application referred to as ‘therapeutic 
metabolomics’(Rabinowitz, Purdy et al. 2011). This method, applied by Dang et 
al (2009), discovered increased levels of 2-hydroxyglutarate in specific mutated 
cancer cells, known to be a common feature in some primary brain cancers 
(Dang, White et al. 2009). 
Currently bacterial metabolomics has focused mainly on the classification 
(Hettick, Green et al. 2008) and understanding of normal bacterial metabolism. 
Schaub et al (2008) found altered  glycolysis dynamics under differing growth 
rates and glucose availability in E. coli  (Schaub and Reuss 2008), whilst Koek et 
al (2006) found a time-related progression of metabolites with bacterial growth 
(Koek, Muilwijk et al. 2006). While interactions between surface topography and 
bacterial adhesion are documented, the effects of targeting bacterial 
metabolism therapeutically are not, and as such remain a novel area of research 
and is therefore the focus of this chapter.  
Recently developed metabolomic methods, specific to the S. aureus biofilm, 
highlighted the metabolic differences between planktonic and biofilm bacterial 
states and the need to study microbes in their different growth states (Stipetic, 
Dalby et al. 2016). By combining this technique and a novel glucose ‘heavy’ 
labelling method, developed by the author, bacterial metabolic pathways 
involved in bacterial adhesion will be identified and therapeutically targeted. It 
should be noted that while the bacterial metabolome has been widely 
researched (Kanehisa and Goto 2000), the specific pathways involved in adhesion 
have not, therefore therapeutic agent selection for targeting will be conducted 
after metabolic pathway identification. 
 
4.2 Chapter Aims 
This study hypothesises that bacterial adhesion is reliant on specific metabolites 
and metabolic pathways. The regulation of which may be affected by altered 
surface nanotopography. The aim of this chapter was to analyse the S. aureus 
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metabolome using LCMS and ascertain any changes in specific metabolites and 
metabolomic pathways. If identified, possible targeted therapeutic agents will 
be analysed to ascertain their effect of bacterial adhesion and subsequent 
biofilm formation.  
Work from this chapter has been published in: 
Hansom D et al THE EFFECTS OF NANOPATTERN SURFACE TECHNOLOGY ON 
ORTHOPAEDIC JOINT REPLACEMENT INFECTION. Bone & Joint Journal 
Orthopaedic Proceedings Supplement, 2015. 97-B(SUPP 3): p. 2. 
Work from this chapter has been presented at the following conferences: 
Hansom D, Tsimbouri M, Ramage G, Burgess K, Dalby M, Meek D and Clarke J. 
‘Nano-topographical modulation of cells and bacteria for next generation 
orthopaedic implants.’ Centre of Cell Engineering – Glasgow Orthopaedic 
Research Initiative, December 2014. 
Hansom D, Burgess K, Meek D, Clarke J, Ramage G. ‘The effects of nanopattern 
surface technology on orthopaedic joint replacement.’ Glasgow Meeting of 
Orthopaedic research, March 2015. 
Hansom D, Burgess K, Meek D, Clarke J, Ramage G ‘Nano-topographical 
modulation of cells and bacteria for next generation orthopaedic implants.’ El-
Minia University Hospital Scientific Day, Egypt, February 2015. 
Hansom D, Burgess K, Gadengaard N, Millar N, Clarke J & Ramage G. ‘The 
effects of nanopattern surface technology on orthopaedic joint replacement.’ 
European Federation of National Associations of Orthopaedics and Traumatology, 
June 2016. 
Hansom D, Burgess K, Gadengaard N, Millar N, Clarke J & Ramage G. ‘The 
effects of nanopattern surface technology on orthopaedic joint replacement.’ 
British Orthopaedic Research Society, September 2016. 
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4.3 Materials and Methods 
S. aureus Newman strain was used for these experiments. Bacteria were 
collected, cultured and standardised under optimal growth conditions as per 
chapter 2. All metabolomics experiments were carried out on Ti control and 
nanowire discs only (3.3.2). 
4.3.1 Metabolomic sample preparation 
In order to highlight any metabolomic differences, heavy labelled glucose (D-
Glucose-13C6, Sigma-Aldrich, Dorset, UK) was substituted for standard glucose in 
DMEM + supplement media. Following bacterial standardisation in heavy labelled 
DMEM + supplement media, 500µL of each sample was added to defined wells in 
a pre-sterilised, standard polystyrene 24-well plate (Corning Incorporated, New 
York, USA) containing nanowire and control titanium discs. The plate was 
incubated at 37oC on a shaking platform for 1 hour. On removal, all supernatant 
was discarded and each disc was gently washed in sterile ammonium bicarbonate 
(10mM). Each Ti disc was transferred to a bijou, and kept on ice. A 1ml: 1g 
mixture of a chloroform, ethanol and ddH20 (CEW, ratio 1:3:1) and acid washed 
glass beads (Sigma-Aldrich, Dorset, UK) was produced and 500µL was added to 
each bijou. Samples were placed on a cell disrupter (Disrupter Genie bead beater, 
Scientific industries Inc., New York, USA) operating at a speed of 3000 rpm, at 
4°C. On removal all the liquid/bead mixture was transferred to an 
microcentrifuge and centrifuged at 10,000 rpm for 10 minutes to remove the 
beads. The supernatant was subsequently transferred to a fresh microcentrifuge. 
A pool sample was produced by adding 10µL of each sample to a separate glass 
vial. Each metabolomic sample vial contained a minimum of 20µL from the 
corresponding microcentrifuge. Samples were then stored at -80oC until 
metabolomic analysis could be performed. This was carried out in triplicate and 
repeated on three separate occasions. 
 
4.3.2 Metabolomic analysis 
Metabolomic data acquisition was carried out using a Thermo Scientific Ultimate 
3000 RSLC system (Thermo Scientific, CA, USA) coupled with a Thermo Scientific 
Exactive Orbitrap system equipped with a HESI II interface (Thermo Scientific, 
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Hemel Hempstead, UK), as per Haggarty et al, 2015 (Haggarty, Oppermann et al. 
2015). Subsequent data analysis was carried out as per Appendix 1. 
 
Metabolomic data was analysed to highlight any peaks resulting from 
incorporation of heavy labelled carbon (ranging from C1-C6). This data was then 
collated and normalised in relation to the intensity of unlabelled carbon in each 
sample. By swapping unlabelled glucose for D-Glucose-13C6 directly before 
nanosurface exposure to bacteria, any unlabelled metabolite peaks were due to 
metabolism that preceded any bacteria/surface interaction. Thus these values 
can be presumed to be constant across all samples and thus used to standardise 
our labelled metabolite results. This allows changes in labelled metabolites to 
be expressed as fold increases and attributed to an increased flux through 
metabolic pathways and not merely due to increased bacterial concentrations. 
4.3.3 Targeted therapeutic metabolomics 
Based on the metabolomics data generated, a targeted approach to investigate 
specific metabolites was performed. Standardised bacteria (2.3.1) in DMEM + 
Supplements were added to pre-defined wells of a 24 well plate (500μL). 
Different concentrations of Β-chloro-L-alanine (β-CLA [250µg/ml, 500µg/ml and 
1000µg/ml]) and cycloserine (CS [12.5µg/ml, 25µg/ml and 50µg/ml]) were added 
to pre-defined wells. In addition, no β-CLA/CS and blank control wells were also 
incorporated.  The plates were incubated in an incubator at 370C for 24 hours. 
Following incubation, supernatant was removed and the biofilms were washed 
with PBS. They were then left to air dry under a hood (Microflow biological 
safety cabinet, Astec, Hampshire, UK), and subsequently stained with 500μL of 
0.05% crystal violet (CV [diluted in ddH2O]) for 20 min. Wells contents were then 
discarded and excess CV washed away using tap water. Plates were tapped to 
ensure all excess CV was removed. Ethanol (1ml of 100%) was added to each well 
and thoroughly mixed to release CV dye. 200μL of each sample was then 
transferred to a clean 24 well flat bottomed plate and OD’s were measured at 
570nm (FLUOstar Omega, BMG labtech). Negative controls containing no 
organisms were included for each β-CLA/CS concentration, and all testing was 
carried out in triplicate on three separate occasions. 
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4.3.4 Minimum inhibitory concentration (MIC) and growth kinetics  
The inhibitory potential of β-CLA and CS on planktonic growth was assessed by 
conducting an inhibitory experiment. Separate stock solutions of β-CLA and CS in 
Mueller Hinton broth (MHB) (Sigma-Aldrich, Dorset, UK) were prepared 
(4mg/ml). 200µl was then added to 5 rows (A-E) in column 1 of a 96-well, round 
bottom, polystyrene microtitre plate (Corning Incorporated, New York, USA). 
Using a multichannel pipette 100µl of MHB was added to 5 wells in columns 2-11 
of the microtitre plate. 100µl was then taken from lane 1, and serially double 
diluted across sequential columns. Standardised inoculum in MHB (1 X 105 
CFU/mL) was then added to columns 1-11 (100µl). Lane 12 was loaded with 
200µl of standardised inoculum (acting as a positive control), while row H 
(columns 1-5) was loaded with 200µl of sterile MHB (acting as a negative 
control). The plates were then incubated at 370C for 24hrs, after which they 
were visually analysed for growth. Subsequently the serial β-CLA and CS 
concentration dilutions were used to analyse the growth kinetics. To achieve 
this, the OD was measured every hour, for 24hrs, allowing identification of any 
effect on bacterial growth kinetics.  
4.3.5 Statistical analysis 
Graph production and statistical analysis were performed using GraphPad prism 
software (version 4; La Jolla, CA, USA). One-way analysis of variance (ANOVA) 
was used to investigate significant differences between groups. If ANOVA 
revealed a statistical significance, a Dunnett’s multiple comparison or Tukey’s 
test was performed to determine statistical significance between groups, 
depending on individual experiments. If two pattern groups were compared, an 
unpaired student’s T-test was employed. Statistical significance was achieved if 
P<0.05.  
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4.4 Results 
Following metabolomic data processing, compounds with increased abundances 
of labelled carbon were identified. The retention times of these peaks were 
then compared to standards from the same run, allowing robust compound 
identification. Each experimental run was carried out on different days due to 
the lengthy sample preparation and processing. Therefore, whilst similar trends 
are noted across all replicates, these cannot be directly compared to one 
another as retention times and comparable standards differ with each 
experimental run. All graphs illustrating retention times and intensities are 
taken from the first experimental run but are representative of three 
experimental runs. Additionally, as all non-labelled carbon was substituted for 
labelled carbon at the start of each experimental run, unlabelled carbon peaks 
were expected to remain static throughout all experiments. These unlabelled 
peaks therefore acted as controls, and subsequent fold changes could be 
calculated for each labelled compound the demonstrated an increased intensity. 
All measured metabolites data can be found on the supplementary CD at the 
back of this thesis. 
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4.4.1 Pyruvate intensity 
Pyruvate showed an increased intensity across all surfaces (Figure 4-1).   
 
Figure 4-1 Labelled pyruvate following metabolomics extraction from S. 
aureus (run 1 data) 
S. aureus Newman strain was standardised in DMEM + supplement media and 
grown on Ti surfaces for a period 1 hour.  Pyruvate abundance is represented by 
the blue (1C labelled), green (3C labelled), brown (4C labelled) and grey 
(unlabelled) line on each graph.  
The fold change in intensity was noted to increase with escalating 
nanoroughness, with the highest intensity fold change being noted on the 3Hr 
treated Ti surface (Figure 4-2). This trend was not found to be significant. 
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Figure 4-2 Fold changes in intensity of labelled pyruvate on different Ti 
surfaces 
Following metabolomic extraction and processing as described, labelled 
pyruvate was noted in all samples, with the highest fold change being present on 
the 3Hr Ti discs. 
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4.4.2 Alanine intensity 
Alanine showed increased intensity across all surfaces (Figure 4-3). 
 
Figure 4-3 Labelled alanine following metabolomics extraction from S. aureus 
(run 1 data) 
S. aureus Newman strain was standardised in DMEM + supplement media and 
grown on Ti surfaces for a period 1 hour.  Alanine intensity count is represented 
by the green (3C labelled) and grey (unlabelled) line on each graph.  
The fold change in intensity was noted to increase with nanoroughness, with the 
highest intensity fold change being significantly higher on the 2.5Hr and the 3Hr 
(P<0.05) treated Ti surfaces when compared to the control Ti surface (Figure 
4-4). No significant difference was noted between the control and 2Hr treated Ti 
surfaces. 
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Figure 4-4 Fold changes in intensity of labelled alanine on different Ti 
surfaces 
Following metabolomic extraction and processing as described, labelled alanine 
was noted in all samples, with the highest fold changes being present on the 
2.5Hr and 3Hr Ti discs (#P<0.05, 1-way ANOVA). 
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4.4.3 Aspartate intensity 
Aspartate intensity was noted to be increased across all surfaces (Figure 4-5). 
 
Figure 4-5 Labelled aspartate following metabolomics extraction from S. 
aureus (run 1 data) 
S. aureus Newman strain was standardised in DMEM + supplement media and 
grown on Ti surfaces for a period 1 hour.  Aspartate intensity is represented by 
the blue (1C labelled), green (3C labelled), brown (4C labelled) and grey 
(unlabelled) line on each graph.  
Fold change in intensity was noted to increase with nanoroughness, with the 
highest intensity fold change being highest on the 3Hr treated Ti surface when 
compared to all other Ti surfaces (Figure 4-6). This trend was not found to be 
significant.  
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Figure 4-6 Fold changes in intensity of labelled aspartate on different Ti 
surfaces 
Following metabolomic extraction and processing as described, labelled 
aspartate was noted in all samples, with the highest fold change being present 
on the 3Hr Ti discs. 
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4.4.4 Carbamoyl-aspartate intensity 
Carbamoyl-aspartate (CA) intensity counts were noted to be increased across all 
surfaces (Figure 4-7). 
 
Figure 4-7 Labelled CA following metabolomics extraction from S. aureus 
S. aureus Newman strain was standardised in DMEM + supplement media and 
grown on Ti for a period 1 hour.  CA intensity count is represented by the green 
(3C labelled), blue (1C labelled), purple (2C labelled), brown (4C labelled) and 
grey (unlabelled) line on each graph.  
The highest fold change appeared to be on the control surface with a gradual 
decline in intensity fold change as nanoroughness increased (Figure 4-8). This 
trend was not significant. 
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Figure 4-8 Fold changes in intensity of labelled aspartate on different Ti 
surfaces  
Following metabolomic extraction and processing as described, labelled CA was 
noted in all samples, with the highest fold change being present on the control 
Ti discs.  
4.4.5 Summary of upregulated metabolites 
The above data is summarised is the table below: 
METABOLITE INTENSITY COUNT (WITH 
INCREASING 
NANOROUGHNES) 
SIGNIFICANT 
PYRUVATE  No 
ALANINE  Yes 
ASPARTATE  No 
CA  No 
 
4.4.6 Unlabelled metabolites 
Whilst the above compounds showed clear increases in labelled intensity counts, 
other compounds that were perhaps expected to be metabolised showed no 
labelling. For example, key metabolites in the citric acid cycle such as acetyl-
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CoA, citrate and oxaloacetate showed no heavy labelling whatsoever. Raw data 
is available on the DVD at the back of this thesis. 
4.4.7 Targeted therapeutic metabolomics 
Metabolite recognition highlighted the movement of labelled compounds, thus 
allowing the identification of upregulated metabolic pathways involved in 
bacterial adhesion. Subsequently, compounds known to inhibit these pathways 
and associated enzymes could be identified and utilised. The exact mechanism 
of action of these compounds and why they were selected is explained in the 
discussion.  
Introduction of beta-chloro-L-alanine (β-CLA), resulted in a reduction in biofilm 
density when stained with CV. As the concentration of β-CLA was increased, the 
biofilm density decreased significantly (P<0.05 for 250µg/ml and 500µg/ml, 
P<0.01 for 1000µg/ml) as shown in Figure 4-9. 
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Figure 4-9 OD measurements of biofilm growth with different β-CLA 
concentrations 
S. aureus Newman strain was standardised in DMEM + supplement media and 
grown, with the addition of different β-CLA concentrations, for a period 24 
hours. Biofilm density was significantly reduced with 250µg/ml and 500µg/ml 
(#P<0.05) and 1000µg/ml (##P<0.01) concentrations, when compared to the no- 
β-CLA control (1-way ANOVA).  
Introduction of cycloserine (CS) resulted in a reduction in biofilm density when 
stained with CV. As the concentration of CS was increased, the biofilm density 
decreased significantly (P<0.001 for 12.5µg/ml, 25µg/ml and 50µg/ml) as shown 
in Figure 4-10. 
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Figure 4-10 OD measurements of biofilm growth with different CS 
concentrations 
S. aureus Newman strain was standardised in DMEM + supplement media and 
grown, with the addition of different CS concentrations, for a period 24 hours. 
Biofilm density was significantly reduced with12.5µg/ml, 25µg/ml and 50µg/ml 
(#P<0.001) concentrations, when compared to the no-CS control (1-way ANOVA).  
4.4.8 MIC and growth kinetics 
Visualisation of the β-CLA plates revealed and MIC of 1000µg/ml. Bacterial 
growth was visually apparent at concentrations lower than this in the form of a 
pellet at the bottom of the well. In contrast, the CS plates revealed a dose 
dependant reduction in bacterial growth with increasing CS concentrations. 
Subsequent 24hr growth kinetics however revealed a dose dependant response 
for both inhibitory compounds over the concentrations range shown in Figure 
4-11 and Figure 4-12. With β-CLA, all concentrations were found to have 
significantly lower OD measurements, when compared to the control (P<0.05, 1-
way ANOVA) with no significant difference between concentrations. CS, 
however, showed a significant difference (P<0.05, 1-way ANOVA) in OD when 
higher concentrations (100,50 and 25 µg/ml) of CS were compared with lower 
concentrations and control (12.5 µg/ml). 
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Figure 4-11 Growth kinetics for S. aureus with different β-CLA concentrations 
S. aureus Newman strain was standardised in DMEM + supplement media and 
grown, with the addition of different β-CLA concentrations, for a period 24 
hours. OD was measured every hour for 24hrs, allowing the growth kinetics to be 
identified (1-way ANOVA).  
 
Figure 4-12 Growth kinetics for S. aureus with different CS concentrations 
S. aureus Newman strain was standardised in DMEM + supplement media and 
grown, with the addition of different CS concentrations, for a period 24 hours. 
OD was measured every hour for 24hrs, allowing the growth kinetics to be 
identified (1-way ANOVA).  
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4.5 Discussion 
Since the emergence of metabolomics in the late 1990’s, this field has rapidly 
advanced and developed (Jellum 1977, Gates and Sweeley 1978, Niwa 1986, 
Bales, Bell et al. 1988, Oliver, Winson et al. 1998, Goodacre, Vaidyanathan et al. 
2004, Dunn, Bailey et al. 2005, Glinski and Weckwerth 2006, Wishart 2008). 
Despite these innovations, bacterial metabolomics (specifically bacterial 
adhesion and subsequent biofilm development) remains an exciting and under 
researched area. As previously suggested surface nanotopography affects 
bacterial adhesion and subsequent biofilm development (Chung, Schumacher et 
al. 2007, Díaz, Schilardi et al. 2008, Ivanova, Truong et al. 2009, McMurray, 
Gadegaard et al. 2011, Xu and Siedlecki 2012). This chapter aims to offer a link 
between bacterial metabolomics and bacterial adhesion. 
Bacterial metabolism refers to a collection of reactions in which molecules are 
broken down primarily to generate energy. In addition, it includes the study of 
uptake and consumption of compounds required for bacterial growth and 
maintenance of a steady state, known as assimilation reactions (Jurtshuk 1996). 
These reactions are catalysed within the bacterial cell via enzymatic systems, 
with the primary end point of bacterial self-replication. Bacterial metabolism 
therefore encompasses the chemical changes that occur to allow microbial cells 
to live, function and replicate. 
Bacteria primarily obtain energy from oxidation of organic compounds; often 
carbohydrate (glucose), lipids and proteins, and are therefore 
chemoorganoheterotrophic (Gottschalk 1986). These carbon and nitrogen 
containing substrates can be used either aerobically or anaerobically to produce 
energy, usually via glycolysis, resulting in the production of pyruvate and energy 
(2xATP per cycle) (Strasters and Winkler 1963). The fate of pyruvate depends on 
the particular environmental conditions and metabolic pathways present within 
the organism, and in the case of bacteria are numerous. By incorporating heavy 
labelled glucose into our growth media, we were able to identify which 
metabolic pathways are utilised by S. aureus during surface adhesion.   
Pyruvate was noted to be heavily labelled (Figure 4-1), in all samples, suggesting 
that glycolysis is occurring, providing the bacteria with an energy source. It also 
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appears that flux through this glycolytic pathway is increased with escalating 
nanoroughened Ti surfaces (Figure 4-2). Whilst not found to be significant, this 
trend suggests that these NW Ti surfaces are somehow causing an up-regulation 
of bacterial glycolysis, and ensuing pyruvate production. The subsequent fate of 
pyruvate is, however, more interesting. High levels of labelled alanine were 
found across all samples (Figure 4-3), suggesting conversion of pyruvate to 
alanine via alanine transaminase (EC:2.6.1.21) (Baba, Bae et al. 2008). The 
absence of labelled compounds such as Acetyl-CoA and oxaloacetate in our 
results suggests that pyruvate does not enter the citric acid cycle but is instead 
almost completely converted to alanine. Alanine is known to be involved in 
peptidoglycan (murein) production (Walsh 1989). In addition, to producing an 
inflammatory response in humans (Timmerman, Mattsson et al. 1993, Card, 
Jasuja et al. 1994), peptidoglycans play a key role within the bacterial cell wall 
(Walsh 1989) and are found on the outside of the cytoplasmic membrane of most 
bacteria (Rogers, Fey et al. 2009). Alanine, in conjunction with other amino 
acids (such as lysine), allows cross-linking between two alternating amino sugar 
chains, forming a mesh-like 3-dimensional peptidoglycan layer (Rogers, Perkins 
et al. 1980), a component of the EPS. This layer has unique properties; it is able 
to withstand changes in osmotic pressure yet is not rigid and remains flexible. 
Wide pores are also noted, thus allowing diffusion of large molecules such as 
proteins (Vollmer, Blanot et al. 2008). Peptidoglycans also act to keep cells 
together after cell division, therefore increasing adherence capacity and 
subsequent biofilm formation (Mercier, Durrieu et al. 2002). These results 
suggest that bacterial aggregation and subsequent biofilm formation is a result 
of increased alanine metabolism, causing up-regulation of peptidoglycan 
production. Alanine, and consequently peptidoglycan production appears to be 
further enhanced by increasing the nanoroughness of the surface to which the 
bacteria is adhering. It is not clear exactly how this up-regulatory mechanism 
works, however it would seem logical for the bacteria to exude all its energy 
into peptidoglycan production, aggregation and biofilm production on a 
nanoroughened surface to which it can easily stick, rather than a polished, 
smooth surface to which it cannot. Could it be that some kind of ‘surface 
identification’ mechanism exists, allowing the bacteria to decide whether it is 
efficient use of energy to attempt surface adhesion? Bacteria are known to 
express and control mechanosensitive potassium channels, allowing a cellular 
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response to membrane tension forces (Vogel and Sheetz 2006, Kobayashi and 
Sokabe 2010). While this response only occurs at high tensions (Kung 2005), thus 
suggesting a cellular lysis-prevention role, it is postulated that a similar 
mechanism exists that allows for surface identification and adhesion modulation. 
Further research in this area, perhaps looking at the bacterial proteomics of 
adhesion, is recommended. 
In addition, labelled aspartate was also noted to be increased across all samples 
(Figure 4-5), again with a step-wise increase in intensity fold change noted with 
escalating nanoroughness (Figure 4-6). Aspartate, or aspartic acid, is an non-
essential amino acid and is recognised as being important in protein metabolism 
as well as being connected to the citric acid cycle component, oxaloacetate 
(Michal and Schomburg 1999). It is also known to be the precursor for lysine, 
methionine, threonine, purines and pyrimidine bases in microorganisms (Oikawa 
2007). As mentioned previously, no labelled compounds involved in the citric 
acid cycle were observed, again suggesting that this cycle is not involved in this 
stage of bacterial growth. While it is recognised that aspartate can be converted 
to alanine, via L-aspartate 4-decarboxylase (Oikawa 2007), our results suggest 
that this may be a reversible reaction and that alanine can also be converted to 
aspartate. Whilst the source of aspartate appears unclear, its subsequent role is 
similar to that of alanine. As mentioned, lysine production is dependent on 
aspartate, which is another amino acid involved in the production of 
peptidoglycans (Royet and Dziarski 2007). This suggests a further increase in this 
metabolic pathway, with the end goal of producing bacterial aggregation and 
peptidoglycan layer formation. In addition to its role in peptidoglycan 
metabolism, aspartate and to some extent lysine, are also recognised to be 
involved in signal transduction in bacteria (Stock, Stock et al. 1990). In E. coli, 
aspartate is thought to be involved in chemotaxis, and when substituted, affects 
chemotaxis via signal transduction (Lukat, Lee et al. 1991). While S. aureus is 
not motile, it is hypothesised that aspartate has some influence on signal 
transduction. 
Aspartate is also a key factor in purine and pyrimidine metabolism (Allison and 
Eugui 1996, Baba, Bae et al. 2008). Both purines and pyrimidines contain 
aromatic rings in their structure, the nucleotides of which function as precursors 
for DNA and RNA synthesis (Hammond and Gutteridge 1984).  It is therefore 
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likely that the increased labelling of aspartate metabolism signifies increased 
production of bacterial DNA, and subsequent bacterial replication. Again a trend 
of increased fold change with nanoroughness was noted, suggesting that 
aspartate production, much the same as alanine production, is up-regulated with 
increased nanoroughness (Figure 4-6). In contrast to alanine however, 
aspartate’s involvement in purine/pyrimidine metabolism (Allison and Eugui 
1996, Baba, Bae et al. 2008) and subsequent bacterial replication (Hammond and 
Gutteridge 1984) suggests that higher aspartate levels should result in increased 
bacterial DNA.  
Further analysis of our metabolomic data has shown high abundance of labelled 
CA (Figure 4-8), a metabolic product of aspartate via carbamoyl-aspartate 
transferase (EC 2.1.3.2). CA is also involved in pyrimidine metabolism (Hammond 
and Gutteridge 1984, Baba, Bae et al. 2008), again implicating the importance of 
this pathway during the adhesion of S. aureus to surfaces. Interestingly however, 
the highest CA fold change was noted on our control surface, with a gradual fold 
change reduction as NW roughness increases. While not significant, this result 
suggests that, on smoother surfaces bacteria channel energy into pyrimidine 
metabolism via CA, rather than purine and peptidoglycan metabolism via alanine 
and aspartate. The relevance of this is unclear, however is may be that given 
that the bacteria appear to be less adherent to smoother surfaces, the pathways 
associated with adherence remain relatively static, whilst planktonic bacterial 
replication remains unaffected.  
Subsequent metabolic cross-referencing with the Kyoto Encyclopedia of Genes 
and Genomes (KEGG) database (Kanehisa and Goto 2000), allowed specific 
metabolic pathways to be identified (Figure 4-13). By ‘heavy’ labelling glucose 
we are able to see how S. aureus uses the glucose provided by the media, and 
into which subsequent pathways this energy is then directed. Following 
conversion to pyruvate, via glycolysis, the two main end points appear to be 
proteoglycan, purine and pyrimidine metabolism. It is logical to assume that this 
is advantageous to the bacteria as it provides bacterial protection, via 
aggregation and biofilm development, as well as bacterial replication through 
nucleotide production and subsequent DNA synthesis. Looking back at the stages 
of biofilm development (Jahoda 2009), adhesion is critical and once achieved a 
cascade of biofilm development ensues. Prevention of this biofilm forming 
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process, by inhibiting the metabolic pathways associated with adhesion, may 
provide a novel target for anti-bacterial therapies.  
Through analysis of the pathways identified (Figure 4-13), a key step in 
peptidoglycan, purine and pyrimidine metabolism is the conversion of pyruvate 
to D-Alanine via D-alanine transaminase (EC 2.6.1.2). This is a reversible 
transamination reaction (Dumitru, Iordachescu et al. 1970), and can thus be 
inhibited by  compounds such as β-CLA, explaining its involvement in this study. 
β-CLA is an amino acid analogue that inhibits a number of enzymes, including 
alanine transaminase (Whalen, Wang et al. 1985). The use of Β-CLA has been 
shown to effectively impair cell growth both in cancer (Beuster, Zarse et al. 
2011) and bacteria (Manning, Merrifield et al. 1974) by preventing the 
production of D-alanine. Alanine is known to be involved in peptidoglycan 
production (Walsh 1989) and plays a key role within the bacterial cell wall 
(Walsh 1989) and is involved in forming the biofilm (Rogers, Perkins et al. 1980). 
Additionally, once formed D-alanine can then be either converted to L-alanine 
(via alanine racemase [EC 5.1.1.1]) or enter peptidoglycan metabolism (via D-
alanine-D-alanine ligase EC 6.3.2.4]). The anti-tuberculosis drug CS is known to 
inhibit both these enzymes (Curtiss, Charamella et al. 1965), thus ensuring its 
use in this study also. CS is a second-line anti-tuberculosis drug and is known to 
inhibit a number of enzymes including alanine racemase and D-alanine-D-alanine 
ligase (Curtiss, Charamella et al. 1965). It is known to have an inhibitory effect 
on hepatocytes (Cornell, Zuurendonk et al. 1984) and cancer cell growth 
(Beuster, Zarse et al. 2011) and is involved in alanine production. It has been 
suggested that CS is a structural analogue of D-alanine and may prevent the 
normal incorporation of alanine in the bacterial cell wall and protein production 
(Neuhaus and Lynch 1964). 
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Figure 4-13 Metabolic pathways linking identified metabolites, adapted from 
(Kanehisa and Goto 2000). 
Following metabolite identification, KEGG referencing shows how these 
metabolites fit into known metabolic pathways in Newman strain of S.aureus. 
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β-CLA was found to have a planktonic MIC of 1000 µg/ml, however biofilm mass 
was found to be significantly reduced at much lower concentrations than this 
(250µg/ml and 500µg/ml (#P<0.05)). Initially it appeared that whilst the 
planktonic bacterial concentrations were not being affected by these β-CLA 
concentrations, the ability of S. aureus to form biofilms was. However, 
subsequent 24hr growth kinetic analysis (Figure 4-11) shows a dose dependant 
type response to increasing β-CLA concentrations, suggesting that inhibition of 
planktonic bacterial growth is also occurring. This implies that β-CLA interferes 
with two key metabolic pathways; firstly by inhibiting D-alanine transaminase 
and subsequent conversion of pyruvate to D-alanine (Beuster, Zarse et al. 2011), 
thus reducing peptidoglycan, purine and pyrimidine metabolism . This impairs 
the ability of S. aureus to adhere, aggregate and form biofilms. Secondly, 
bacterial DNA replication (reliant of purine and pyrimidine metabolism) will also 
likely be affected which will affect planktonic bacteria and biofilm formation 
alike. While β-CLA is not clinically used as an anti-microbial, its effects on S. 
aureus are clear, thus its use perhaps as an implant coating of for local 
treatment should be considered. Further research relating to β-CLA’s effect on 
other cell lineages is merited.   
Similar results were also noted with the addition of CS (4.3.4), and growth 
kinetic analysis again showed a dose dependent type response in relation to 
differing CS concentrations. In addition, no clear MIC was noted, suggesting that 
CS perhaps has a more bacteriocidal effect on planktonic cells. As previously 
mentioned, CS is used in the treatment of tuberculosis and acts by inhibiting 
alanine racemase and D-alanine-D-alanine ligase (Curtiss, Charamella et al. 
1965), resulting in inhibition of peptidoglycan, purine and pyrimidine metabolism 
(Figure 4-13). Again while this will clearly affect biofilm formation, it also 
influences bacterial replication and thus has implications on both planktonic 
cells and biofilm formation. In addition, CS is known to penetrate the central 
nervous system, and thus can have several neurological side effects such 
as headaches, depression, dizziness, confusion, dysarthria and psychosis to name 
a few (Nitsche, Jaussi et al. 2004). Further research into its clinical use is 
therefore recommended. 
In conclusion, it is evident that surface adhesion of S. aureus is reliant on 
specific metabolites and pathways. Our novel labelling techniques combined 
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with LC-MS has allowed identification of these metabolites and pathways, thus 
opening the door to targeting therapeutic treatments. Our pilot study suggests 
that compounds such as β-CLA and CS inhibit key bacterial adhesion pathways, 
with the later also potentially having a bacteriocidal affect. It must be stressed, 
however, that these agents do have known side effects and that their influence 
on other cell lineages is largely unknown. Further research is therefore 
recommended. 
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5.1 Introduction 
Implantable medical devices or biomaterials are used extensively in orthopaedic 
joint replacements (Scottish-Arthoplasty-Project 2014, 
ScottishArthoplastyProject 2014). Successful arthroplasty relies primarily on 
good osseointegration (Willert and Buchhorn 1998) and prevention of post-
operative complications (1.2). Staphylococcus species are frequently isolated 
from orthopaedic infections, namely S. aureus and S. epidermidis (Garvin, 
Hinrichs et al. 1999, Nickinson, Board et al. 2010), which constitutes just over a 
third of all confirmed prosthetic joint infections (Trampuz and Widmer 2006).  
Arthroplasty failure due to infection is largely due to biofilm production, a 3D 
matrix produced and secreted by the bacteria that involves a series of co-
ordinated molecular events (Fux, Stoodley et al. 2003). Additionally it provides a 
protective coating, thus allowing the bacteria to withstand high doses of 
particular antibiotics that would kill planktonic cells outright (Bjarnsholt 2013). 
The initial adhesion phase of complex biofilm formation is critical (Mack, 
Nedelmann et al. 1994, Heilmann and Götz 1998, Jahoda 2009), and is affected 
both by material surface topography (Ivanova, Truong et al. 2009, McMurray, 
Gadegaard et al. 2011, Ivanova, Hasan et al. 2012, Xu and Siedlecki 2012, 
Sjöström, Brydone et al. 2013) and metabolic pathway activation (Kanehisa and 
Goto 2000, Stipetic, Dalby et al. 2016). In addition, bacterial metabolomic 
profiling has focused primarily on normal growth (Schwab, Watson et al. 1955, 
Koek, Muilwijk et al. 2006, Hettick, Green et al. 2008, Schaub and Reuss 2008), 
without focus on biofilm formation or production. It is postulated that advances 
in nanopattern fabrication techniques (Sjöström, Dalby et al. 2009, Sjöström, 
Brydone et al. 2013) and metabolomic analysis (Wishart 2008, Dudley, Yousef et 
al. 2010, Wang, Larson et al. 2011, Patti, Yanes et al. 2012) will improve our 
understanding  and subsequent clinical management of these infections, 
benefiting the patient, the NHS and society. 
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5.2 Optimising biofilm growth in S. aureus 
Multiple methods of standardising, optimising and quantifying staphylococcal 
biofilm growth exist (Bergamini, Bandyk et al. 1989, Atanassova, Meindl et al. 
2001, Alarcon, Vicedo et al. 2006, Stepanović, Vuković et al. 2007), however, a 
generic method, used by the majority is not readily recognised.  Historically, a 
multitude of different growth media have been used for staphylococcal culture 
(May, Houghton et al. 1964, Christensen, Simpson et al. 1982, Safdar, Narans et 
al. 2003). However, it was felt that none could be incorporated into future MSC 
co-culture studies. Osseointegration is essential for long-term survival of TJR; 
thus our culture medium had to be optimal for culture of MSCs as well as 
bacteria. DMEM + supplements media has been used extensively in cell culture 
laboratories (Webber, Harris et al. 1985, Palmer, Schwartz et al. 2001, Dalby, 
Cates et al. 2004). Our results show that DMEM + supplements caused 
predictable bacterial growth when compared to other growth media (2.3.1.3). In 
addition, it would allow subsequent co-culture experimentation with MSCs to be 
carried out if necessitated, thus increasing its clinical relevance.   
Bacterial biofilm growth is a time dependant phenomenon, with adhesion being 
the critical stage. This is essentially a battle between tissue cell integration and 
bacterial adhesion to the same surface (Gristina, Hobgood et al. 1987).  If 
adhesion can be prevented, subsequent developmental stages can be averted, 
thus reducing THR infection rates. Adhesion is recognised as being a two-phase 
process consisting of an initial, reversible and instantaneous phase (phase one or 
docking phase) and a second time-dependant, irreversible molecular and cellular 
phase (phase two or locking phase) (Dunne 2002, Katsikogianni and Missirlis 
2004, Barbu, Mackenzie et al. 2014). Whilst significant literature exists defining 
and characterising these stages (Costerton, Cheng et al. 1987, Costerton, 
Stewart et al. 1999, Donlan and Costerton 2002, Dunne 2002, Hall-Stoodley, 
Costerton et al. 2004), little exists in relation to the time periods of the specific 
biofilm development phases. Phase two adhesion of bacterial to plant root 
systems is suggested to occur within 5 min of exposure (James, Suslow et al. 
1985), however, research with respect to clinically relevant bacteria and 
biomaterial adhesion is scarce. Given that adhesion is recognised as a ‘race to 
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the surface’, being able to accurately establish a time course for this event is 
essential. Our growth curve data provided a rough adhesion time frame of 0 to 2 
hours after bacteria/surface exposure (2.3.1.3). A more exact quantification 
method was subsequently employed to allow precise time frame detection. 
Multiple bacterial quantification methods exist, each with specific advantages 
and drawbacks (2.3.2.3). Quantitative PCR is used extensively in dental 
(Williams, Trope et al. 2006) and medical (Larsen, Vogensen et al. 2010) fields, 
and was utilised in this study to provide a real time quantification of bacterial 
DNA. This allowed identification of a pre-exponential growth period, felt to 
represent the adhesion/aggregation phase of bacterial growth, directly before 
the next stage of development, maturation (exponential bacterial growth). 
Recognition of this optimal bacterial incubation period (60 min), allowed us to 
accurately analyse bacterial adhesion in subsequent experiments. When 
combined with an optimised qPCR technique (2.3.3.2), precise bacterial 
quantification at the adhesion phase of biofilm development was achieved. 
Whilst the qPCR technique is highly sensitive and specific (Yang, Habib et al. 
2007, Smith and Osborn 2009), it is limited by its inability to discriminate 
between live and dead cells (Àlvarez, González et al. 2013). The importance of 
this in our study however is negligible, as it was assumed that only live bacteria 
could adhere to a surface. Future studies and techniques that focus on live/dead 
qPCR, such as those described by Alvarez et al (2013) and Sherry et al (2016) 
may be on benefit in this regard (Sherry, Lappin et al. 2016). 
 
5.3 Biofilms and nanotopographies 
Whilst adhesion is dependent on cell-surface interactions (3.1), alterations to 
the surface topography at a nanoscale have also been shown to have major 
effects on cell behaviour (McMurray, Gadegaard et al. 2011), bacterial adhesion 
(Xu and Siedlecki 2012) and ultimately long term implant survival (Sjöström, 
Brydone et al. 2013). The exact effects of surface topography are somewhat 
confusing. While some studies suggest increased surface roughness reduces 
bacterial adhesion and subsequently biofilm formation (Ivanova, Truong et al. 
2009, Ivanova, Hasan et al. 2012, Xu and Siedlecki 2012, Ivanova, Hasan et al. 
2013), others imply that bacteria show no preference to surface topography and 
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disregard surface roughness as factor in adhesion (Scheuerman, Camper et al. 
1998, Taylor, Verran et al. 1998, Bos, van der Mei et al. 1999). The sheer 
existence of these studies, in conjunction with MSC research on nanosurfaces 
(Dalby, Gadegaard et al. 2007, Hart, Gadegaard et al. 2007, Dalby, Andar et al. 
2008) provides a strong case for surface nanotopography affecting cellular 
attachment, regardless of whether it enhances or inhibits adhesion. 
The large variation between different nanosurfaces and materials is highlighted 
in this study. While no significant difference was shown between differing 
polystyrene nanopit arrays (3.4.1), a trend towards reduced adhesion on ordered 
nanopit structures and increased adhesion on disordered arrays was 
demonstrated. Similar observations have been noted in MSC studies, suggesting 
adhesion promotion by disorder and adhesion inhibition by ordered nanopit 
arrays (Dalby, Andar et al. 2008). Further MSCs studies suggest gene expression 
is affected by nanotopography (Dalby, Gadegaard et al. 2007, Dalby, Andar et al. 
2008), therefore it may be that these mechanisms are also occurring in bacteria 
during adhesion. This theory would benefit from further genomic or proteomic 
studies and may provide novel antibacterial nanopit surfaces. It has also been 
suggested that bacterial micro-colony formation can be prevented by creating a 
physical barrier to spread at a nanometre level (Chung, Schumacher et al. 2007). 
It may be that the organised SQ and HEX nanopatterns in our study are the 
optimal nanopit orientations to prevent bacteria microcolony formation, keeping 
the bacteria in small, isolated clusters and preventing communication. A study 
by Diaz et al (2009) focusing on Pseudomonas fluorescens found reduced 
adhesion to parallel nanometre channels and concluded that sub-micropatterns 
are influential on bacterial colonisation strategies. It was felt that these ordered 
arrays posed a physical barrier to the bacteria, requiring a higher energy 
expenditure to ‘overcome’ the channel walls (Díaz, Schilardi et al. 2008). It is 
postulated that similar interactions may be occurring between bacteria and our 
polystyrene nanopit ordered arrays, namely SQ and HEX, however further studies 
are required to confirm this theory. 
This hypothesis was further supported moving onto more clinically relevant 
materials such as Ti. We found fabricated NW Ti to significantly affect bacterial 
adhesion, with and exponential rise in bacterial concentration with increasing 
nanoroughness (3.3.2). These NW surfaces are noted to be highly disordered, and 
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therefore inducive to increased bacterial adhesion as previously theorised.  
Additionally it has been suggested that such surfaces provide increased contact 
guidance (Díaz, Schilardi et al. 2008), perhaps allowing quicker attachment and 
biofilm production. This was demonstrated by our SEM imaging of bacterial 
surface interactions, where increased bacterial aggregation and clumping on 
rougher nanosurfaces was illustrated (3.4.2.3) .  Finally, it should be noted that 
while these disordered NW surfaces contained surface depressions that may 
invoke bacterial collection and adhesion, they did not exhibit any 
nanoprotrusions that have also been shown to affect bacterial growth (Ivanova, 
Truong et al. 2009, Ivanova, Hasan et al. 2012, Ivanova, Hasan et al. 2013). 
While nanoprotrusions have been studied on materials such as black silicon 
(Ivanova, Hasan et al. 2013) and polyurethane (Xu and Siedlecki 2012), the 
incorporation of such nanoprotrusions onto clinically relevant materials (Ti) was 
innovative and unique. Our NC pattern, hexagonal in nature, showed a 10-fold 
reduction in bacterial adhesion when compared to a control, polished Ti surface 
(3.4.2.1). Similar nanopillar structures found on dragonfly wings (Ivanova, Hasan 
et al. 2012) and black silica (Ivanova, Hasan et al. 2013) have shown 
bacteriocidal properties. It is postulated that cell death occurs as a result of 
altered surface structure and stresses resulting in a forced cell deformation 
(Ivanova, Hasan et al. 2013). Additionally, our NC patterns were noted to have 
sharp edges with a pyramidal tip, characteristics that have been shown to cause 
significant cell membrane damage, resulting in cell lysis (Gorth, Puckett et al. 
2012). The ability to kill bacteria that attach to a clinically relevant material 
based purely on surface structure is a novel area of research. While the effects 
of these surfaces on MSCs and osseointegration negates further research, the 
potential for application in implant development and as an alternative to 
chemical based treatments is vast. 
 
5.4 Biofilm metabolomics 
While multiple mechanical theories as to the mechanism behind bacterial 
adhesion exist (Fletcher and Loeb 1979, Paul and Loeb 1983, Fletcher 1996, 
Dunne 2002), it has been suggested that adhesion is mediated by surface 
Ch.5 Final Discussion 
 112 
proteins (Hussain, Herrmann et al. 1997), extracellular proteins (Heilmann, 
Schweitzer et al. 1996), adhesins (McKenney, Hübner et al. 1998) and autolysins 
(Heilmann and Götz 1998). The metabolomic pathways underlying these 
mechanisms remain an under investigated research area. Despite the rapid 
advancement and development of metabolomic techniques (Jellum 1977, Gates 
and Sweeley 1978, Niwa 1986, Bales, Bell et al. 1988, Oliver, Winson et al. 1998, 
Goodacre, Vaidyanathan et al. 2004, Dunn, Bailey et al. 2005, Glinski and 
Weckwerth 2006, Wishart 2008) bacterial metabolomics studies (specifically 
bacterial adhesion and subsequent biofilm development) remain scarce. The 
novel incorporation of labelled glucose into our media allowed the identification 
of metabolic pathways utilised by S. aureus during adhesion. Our results indicate 
up-regulation of glycolysis, peptidoglycan, purine and pyrimidine metabolism 
characterised by fold increases in pyruvate, alanine, aspartate and CA (4.4). The 
importance of these pathways is well documented, playing key roles in the 
bacterial cell wall (Rogers, Perkins et al. 1980, Walsh 1989), EPS production 
(Rogers, Perkins et al. 1980), adherence (Mercier, Durrieu et al. 2002), 
aggregation and DNA/RNA synthesis (Hammond and Gutteridge 1984). 
Furthermore, the absence of labelled compounds such as Acetyl-CoA and 
oxaloacetate in our results suggests that pyruvate does not enter the citric acid 
cycle but is instead almost completely converted to alanine. This unexpected 
result suggests that in the initial phase of bacterial exposure to a surface, 
energy is preferentially directed into pathways providing bacterial protection 
(via EPS and thus biofilm production) and replication (via increased RNA/DNA 
synthesis). What’s more, this response is amplified as Ti nanoroughness 
increases, with higher fold changes in pyruvate, alanine and aspartate being 
noted on 3Hr NW Ti in comparison to smooth control Ti surface (0). This, in 
conjunction with lower fold changes in CA on 3Hr NW Ti, suggests that on 
roughened surfaces, energy is directed to peptidoglycan and purine metabolism, 
whilst on smoother surfaces pyrimidine metabolism is favoured. The theory 
behind this is not clear; however one explanation may be in relation to contact 
guidance. Increasing nanoroughness is known to provide increased contact 
guidance (Díaz, Schilardi et al. 2008). It may be that metabolic pathway 
activation in bacteria is dependent on the degree of contact guidance available; 
i.e. low contact guidance results in increased bacterial replication as adhesion is 
not possible, while high contact guidance results in increased purine and 
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peptidoglycan production thus inducing adhesion. Certainly in MSCs studies, 
increasing contact guidance has positive effects on epithelial cell growth 
(Teixeira, Abrams et al. 2003). Bacterial research in this field however, remains 
scarce and may prove beneficial in future studies. 
Subsequent identification and use of therapeutic agents that target these 
pathways provided a clinical angle to our metabolomic analysis. While multiple 
antibiotics are used to try and treat infection, few are aimed directly at 
preventing bacterial adhesion to implants. Both therapeutic agents in our study 
were chosen based on their ability to inhibit the identified bacterial adhesion 
pathways. While both our inhibitory compounds (β-CLA and CS) were found to 
reduce biofilm growth (4.3.3), this was a dose dependant phenomenon, 
suggesting that inhibition of planktonic bacterial growth was also occurring. 
More specifically, our results suggest that β-CLA works on two key metabolic 
pathways; firstly by inhibiting D-alanine transaminase and subsequent conversion 
of pyruvate to D-alanine (Beuster, Zarse et al. 2011), thus reducing 
peptidoglycan, purine and pyrimidine metabolism. This impairs the ability of S. 
aureus to adhere, aggregate and form biofilms. Secondly, bacterial DNA 
replication (reliant of purine and pyrimidine metabolism) will also likely be 
affected which will affect planktonic bacteria and biofilm formation alike. 
Differentiation between these two potential modes of action would be an 
interesting focus of future research.  A similar dose dependant type response 
was noted with the addition of CS to our bacterial cultures. Interestingly, 
however, no clear MIC was noted, suggesting that CS perhaps has a more 
bacteriocidal effect on planktonic cells. As previously mentioned, CS is used in 
the treatment of tuberculosis and acts by inhibiting alanine racemase and D-
alanine-D-alanine ligase (Curtiss, Charamella et al. 1965), resulting in inhibition 
of peptidoglycan, purine and pyrimidine metabolism. Again, while this will 
clearly affect biofilm formation, it also influences bacterial replication and thus 
has implications on both planktonic cells and biofilm formation. In addition, CS is 
known to penetrate the central nervous system, and thus can have several 
neurological side effects such as headaches, depression, dizziness, confusion, 
dysarthria and psychosis to name a few (Nitsche, Jaussi et al. 2004). Further 
research into its clinical use is therefore recommended. 
Ch.5 Final Discussion 
 114 
It is evident that by targeting metabolic pathways with therapeutic treatments 
such as β-CLA and CS, bacterial adhesion and thus biofilm development can be 
influenced. While the potential benefits of such treatments is clear, these 
agents do have known side effects and their influence on other cell lineages is 
largely unknown. Further research is therefore recommended. 
 
5.5 Future work, study limitations and clinical relevance. 
This body of work has optimised the surface adhesion phase of biofilm 
production in S. aureus, allowing the effects of different materials and 
nanotopographies on this growth period to be evaluated. Further labelled 
metabolomic analysis has highlighted the specific metabolites and pathways 
involved in this process. Whilst a specific time frame for the initial adhesion 
phase of bacterial growth was documented, subsequent S. aureus biofilm studies 
would benefit from further analysis using similar techniques used in this study. In 
addition, incorporation of a co-culture model involving both S. aureus and MSCs 
may elicit changes in the growth kinetics of both cell lineages and subsequently 
may affect cellular adhesion and metabolism. If successful, such co-cultures 
could also be translated to our nanopattern materials, thus providing a more 
accurate representation of the implant in situ. A further aspect that was not 
addressed in the present study was surface hydrophobicity. While several studies 
suggest that hydrophobic surfaces delay adhesion and hydrophilic surfaces 
promote attachment (Quirynen, Van Der Mei et al. 1994, Tang, Cao et al. 2009, 
Loo, Young et al. 2012), opposing studies also exist (Sousa, Teixeira et al. 2009). 
While the cicada wing (on which our NC and NG surfaces are based) has an 
antibacterial effect that is not influenced by hydrophobicity (Ivanova, Hasan et 
al. 2012), our polystyrene nanopits and Ti NW surfaces would benefit from 
future hydrophobicity studies. A further limitation of our study was the isolated 
use of staphylococcus species, and later solely S. aureus Newman strain. 
Although the results in this thesis are compelling for this strain, the effects of 
such nanotopographies on other bacterial strains may be entirely different. With 
thousands of bacterial pathogens in existence, future investigation combining 
techniques developed in this study and different bacterial species would be 
interesting and warranted. 
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The use of metabolomic labelling analysis in bacteria has highlighted some 
important metabolites and pathways used in the adhesion of S. aureus to 
different surfaces. Though interesting in its own right, metabolic pathway 
identification also opens the door to targeted therapeutic treatments. Two such 
agents were subsequently analysed in this study based on their ability to inhibit 
identified adhesion pathways. Although these agents both reduced biofilm 
production, dose dependant responses were noted suggesting the inhibition of 
planktonic bacterial growth with or without biofilm growth inhibition. Further 
research perhaps analysing the mature biofilms response to such agents may 
provide more information. In addition, future research may focus on the effects 
of such agents on other cell lineages, addressing known side effects and 
exploring the possibility of local coverage of implants, rather than systemic 
applications. Given the current concerns regarding antimicrobial resistance 
(Appelbaum 1992, Cohen 1992, Organization 2001, Livermore 2002), the further 
development of targeted metabolomics may deliver therapeutic agents that can 
provide antibacterial treatments for medical implants in the future.  
5.6 Conclusions 
Our study shows that by altering nanotopography, bacterial adhesion and 
therefore biofilm formation can be affected. Specific nanopatterned surfaces 
may reduce implant infection associated morbidity and mortality. The 
identification of metabolic pathways involved in adhesion allows for a targeted 
approach to biofilm eradication in S. aureus. This is of significant benefit to the 
patient, the surgeon and the NHS, and may well extend far beyond the realms of 
orthopaedics. 
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Appendix 1 - C13 Analytical Method and 
Processing 
 
The column was maintained at 30°C and samples were eluted with a linear 
gradient (20 mM ammonium carbonate in water (A) and acetonitrile (B) over 26 
min at a flow rate of 0.3 ml/min as follows: 
 
Time (minutes) % water % acetonitrile 
0 20 80 
15 80 20 
15 95 5 
17 95 5 
17 20 80 
24 20 80 
 
The injection volume was 10 μl and samples were maintained at 4°C prior to 
injection. For the MS analysis, a Thermo Orbitrap Exactive (Thermo Fisher 
Scientific) was operated in polarity switching mode and the MS settings were as 
follows:  
 
• Resolution 50,000 
• AGC 106 
• m/z range 70–1400 
• Sheath gas 40 
• Auxiliary gas 5 
• Sweep gas 1 
• Probe temperature 150°C 
• Capillary temperature 275°C 
 
For positive mode ionisation: source voltage +4.5 kV, capillary voltage +50 V, tube 
voltage +70 kV, skimmer voltage +20 V. 
For negative mode ionisation: source voltage-3.5 kV, capillary voltage-50 V, tube 
voltage-70 V, skimmer voltage-20 V. 
 
Mass calibration was performed for each polarity immediately prior to each 
analysis batch. The calibration mass range was extended to cover small 
metabolites by inclusion of low-mass contaminants with the standard Thermo 
calmix masses (below m/z 1400), C2H6NO2 for positive ion electrospray 
ionisation (PIESI) mode (m/z 76.0393) and C3H5O3 for negative ion electospray 
ionisation (NIESI) mode (m/z 89.0244). To enhance calibration stability, lock-mass 
correction was also applied to each analytical run using these ubiquitous low-mass 
contaminants. 
 
Thermo Scientific .raw LC-MS flies were converted to mzXML format using 
proteowizard (Kessner, Chambers et al. 2008). The resultant mzXML files were 
processed using XCMS to pick peaks (Tautenhahn, Böttcher et al. 2008) with 
mzMatch to filter, match and annotate the peaks. mzMatch-ISO was used to select 
and group labelled peaks for statistical analysis (Chokkathukalam, Jankevics et al. 
2013). 
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